HealthLine Health News

Sugar-sweetened drinks and alcoholic beverages have been linked to a higher risk of hair loss. Alejandro Moreno de Carlos/Stocksy United A new research review indicates that sugary drinks and alcoholic beverages can contribute to hair loss. However, certain nutrients, like vitamin D, iron, and protein, can help promote healthy hair. When prioritizing nutrition isn’t enough to manage hair loss, it’s essential to get treatment sooner rather than later. For many people, maintaining healthy hair goes beyond a good hair cut or buying the latest products. According to new research, hair health begins with a nutritious diet. A review published on August 21 in Nutrition and Health suggests that what you eat can affect hair growth, strength, and even hair loss. The analysis shows that sugar-sweetened beverages and alcoholic drinks were associated with a higher risk of hair loss, but also indicates that certain nutrients can promote healthy hair. From vitamins and minerals to specific foods and drinks, the findings offer practical tips for anyone wanting to support their hair health. Reviewing the effects of diet and nutrition on hair loss For the review, researchers followed PRISMA guidelines, considered the gold standard for systematic reviews, and registered their work on PROSPERO. They scoured three big scientific databases — PubMed, Web of Science, and Scopus — looking for studies published between March and June 2024. Using keywords like “dietary intake,” “nutritional status,” “hair growth,” and “hair loss,” they started with 1,287 articles. After filtering for English and Portuguese studies and removing duplicates, 880 remained. Two reviewers independently checked which studies fit their criteria: participants had to be 3 years or older, studies had to focus on specific nutrients or foods, and hair outcomes had to include things like growth, texture, or strength. Non-human studies, reviews, and case reports were left out. Eventually, 17 studies made the cut. They included more than 61,000 participants — mostly females ages 7 to 77 — and spanned different study types like randomized trials, case-control studies, and cohort studies. The researchers also assessed the quality of each study, finding some variability, but overall the results offered a clear picture of what we currently know. The review further highlighted that alopecia was the most frequently studied hair condition, with eight studies focusing on its severity and occurrence, and five studies assessing hair loss more generally.  Various assessment methods were used, ranging from clinical history and physical examination to objective measures like the Severity of Alopecia Score (SALT) and phototrichograms, ensuring a broad evaluation of hair health outcomes. Vitamin D, other nutrients promote hair health Among the nutrients studied, vitamin D emerged as the most extensively researched, with five studies focusing on its relationship to hair conditions such as alopecia areata (AA) and androgenetic alopecia (AGA).  Most of these studies found an inverse correlation between vitamin D levels and the severity or duration of alopecia, suggesting that higher vitamin D status may be protective against these hair loss disorders.  However, one study did not find any association, highlighting the need for further clarification. Iron was another nutrient highlighted for its positive impact on hair health.  One study showed that iron supplementation (100-milligram tablets) improved hair growth among women with alopecia, supporting the role of iron in hair follicle metabolism and cellular proliferation.  Conversely, protein deficiency was found to negatively affect hair health by reducing hair bulb diameter and pigmentation, emphasizing the importance of adequate protein intake for keratin production, the key structural protein in hair. Foods, drinks, and supplements that affect hair health The review also examined the role of specific foods and beverages as well as certain supplements commonly used for preventing hair loss and encouraging better hair growth. Consumption of soy products and cruciferous vegetables was associated with reduced hair loss, possibly due to their antioxidant and anti-inflammatory phytochemicals such as isoflavones and carotenoids.  On the other hand, higher intake of alcoholic and sugary beverages was linked to increased hair loss and premature hair depigmentation.  These findings suggest that certain dietary choices can exacerbate or mitigate hair health issues. In addition to individual nutrients and foods, several studies investigated the effects of dietary supplements containing combinations of vitamins, minerals, and plant extracts.  Supplements such as INVERSION Femme (which includes green tea and grape extracts, beta-carotene, zinc, selenium, and various vitamins) and marine protein formulations showed promising results in reducing hair loss and promoting hair growth.  Similarly, oral supplementation with hydrolyzed eggshell membrane and persimmon leaf extract was associated with improvements in hair density and thickness. Dietary guidance for healthy hair Marie Jhin, MD, a board certified dermatologist and chief medical officer at Musely, told Healthline that hair follicles are metabolically active, so they are reliant on a steady supply of nutrients. “I encourage patients to eat a diet rich in lean proteins, fruits, vegetables, and whole grains,” she said, noting the importance of iron, zinc, vitamin D, and biotin, as well as omega-3 fatty acids, which can be found in fish, flax, and walnuts. “Even mild deficiencies in these nutrients can affect hair growth and quality,” said Jhin. When it comes to supplements, she advised that most people can get adequate nutrition from foods; however, supplements can be helpful when there are dietary restrictions or proven deficiencies. “Vitamin D and iron are two common deficiencies I check for in patients with hair loss, and supplementation can make a difference if levels are low,” she said. Jhin further spoke about biotin, which is often marketed for hair health. “[While] it may help some individuals, it is usually most effective in people who are deficient, which is relatively rare,” she explained. Jhin recommended speaking with a physician before starting any supplements since over-supplementation may do more harm than good. When good nutrition isn’t enough Susan Massick, MD, a board certified dermatologist at The Ohio State University Wexner Medical Center, emphasized the importance of maintaining overall health. “Get regular physicals and health exams, follow your physician’s recommendations, lower your stress levels, eat a healthy, well-balanced diet, avoid smoking, and get plenty of rest,” she told Healthline. “Be gentle with your hair care.” However, if you are experiencing hair loss, Massick stated that it’s important to start treatment early, especially if you’re genetically at risk for hair loss. (Healthline’s FindCare tool can be an invaluable tool for locating a dermatologist near you who treats hair loss.) “[Don’t] wait for it to become so obvious that it is hard to cover up,” she said. Massick noted that there are multiple types of effective treatments for hair loss, depending on what is causing it. This can include medications like minoxidil, finasteride, dutasteride, and spironolactone, as well as treatments like protein-rich plasma, low-level laser therapy, and, as a last resort, hair transplant surgery. Finally, Massick said that it’s important to be patient when treating hair loss, since it can take at least six months to see improvement.

New restrictions for COVID-19 shots could lead to an uptick in cases, especially among vulnerable populations. juanma hache/Getty Images The FDA approved updated COVID-19 shots for the fall, but federal health officials have changed their recommendations on who should receive them. The new vaccines are expected to contain updated formulas to fight the latest strains of the virus and should be available around mid-September. Experts are concerned that new policies regarding COVID-19 vaccine eligibility could increase the number of cases, especially among vulnerable populations. A late-summer COVID-19 surge with the new “Stratus” omicron subvariant has left many Americans wondering whether they’re eligible for updated COVID-19 shots this fall. Health experts are concerned about the potential for increased spread of COVID-19 and other infectious diseases after some recent decisions by the Trump administration involving vaccines. On August 27, the FDA approved updated COVID-19 shots with restrictions for many adults and children. The FDA will limit COVID-19 vaccinations to “high risk” younger adults and children with at least one chronic health condition like obesity or asthma. In addition, children under 5 will no longer have access to Pfizer’s COVID-19 vaccine, but will be eligible for shots from Moderna and Novavax. This could mean millions of Americans will have to prove their case for vaccination, and healthy adults and children who wish to get vaccinated against COVID-19 will no longer be eligible. According to new clinical guidelines from the American College of Cardiology, people with cardiovascular disease should be made eligible for the new shots. The ACC recommends vaccination against respiratory illnesses, including COVID-19, influenza, and RSV, for people with heart disease. All U.S. adults 65 and older are still eligible for vaccination against COVID-19. The policy shifts for COVID-19 shots began in May when the Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) announced they were no longer recommending the COVID-19 vaccine to healthy adults under 65, pregnant people, and healthy children. Then, in early August, Health and Human Services Secretary Robert F. Kennedy Jr. said that his agency would eliminate $500 million in funding for 22 mRNA vaccine development programs. The following week, Kennedy’s agency announced it was reviving the Task Force on Safer Childhood Vaccines, a move that some experts say could lead to anti-vaccination policies. The announcements come as the CDC reports that the number of children who haven’t received recommended vaccines has hit a record high, while measles cases in the United States have reached their highest mark in 33 years. These actions recently prompted the American Academy of Pediatrics (AAP) to update its recommendation on COVID vaccines. The AAP urges parents to have their children ages 6 months to 18 years vaccinated against the respiratory disease that caused a worldwide pandemic in 2020. Experts interviewed by Healthline say these new developments could have serious consequences in the coming months. “With fewer persons vaccinated, we can anticipate an increase in hospitalizations, intensive care unit admissions, and even deaths during the coming winter season,” said William Schaffner, MD, an infectious disease specialist and a professor of medicine at Vanderbilt University. “It’s a really scary proposition that vaccines might not be available to everyone,” added Danelle Fisher, MD, a pediatrician at Providence Saint John’s Health Center in Santa Monica, CA. “We may see what havoc COVID can still cause. Fasten your seat belts.” Restricting COVID-19 shots could cause a surge in cases It’s unclear when the latest batch of COVID-19 vaccines will be available, but experts say mid-September is likely the date. The new vaccines are expected to contain updated formulas to combat the latest strains of the novel coronavirus. Steven Jensen, MD, a pediatrician and medical director of General Pediatrics at Miller Children’s & Women’s Hospital in Long Beach, CA, said there should be enough COVID-19 supply to ensure anyone who wants to get vaccinated can do so. Jensen said that manufacturers have increased production, and most pharmacies, clinics, and doctor offices should have adequate supplies. However, he noted that some rural areas may face shortages. He noted that the biggest issue is whether people will want to get vaccinated, especially given the changes to the CDC and FDA recommendations. “The difficulty will not be having enough vaccines available,” Jensen told Healthline. “I believe the main difficulty will be vaccine fatigue, as people will be less motivated to get updated boosters, leading to lower demand.  Also, there is significant misinformation and mistrust about the vaccine safety, which can impact the willingness of patients to receive this vaccine.” There are other complications, too. Politico reports that pharmacies in 18 states and Washington, D.C., have their authority to vaccinate individuals linked to CDC guidelines. That could mean pharmacists in those regions may be reluctant to administer vaccines to people unless they are at least 65 years old or have underlying medical conditions. According to Politico, nearly 90% of COVID-19 vaccine doses during the 2024–2025 season nationally were given at pharmacies. There’s also the possibility that healthy people who are providing care to people who are vulnerable to COVID may not be able to get vaccinated. Jake Scott, MD, an infectious disease specialist and a clinical associate professor of medicine at Stanford University in California, adds that insurance companies may also require people who don’t meet the CDC guidelines to pay for their vaccinations. “We’re creating a system where your ability to protect yourself and your family depends on your ability to pay,” he told Healthline. Fisher pointed out that healthy babies, as well as people being treated for cancer and those with underlying medical conditions, will be at risk. That, she said, will affect everybody. “The most vulnerable will be the ones hit first,” Fisher told Healthline. “I don’t know anybody who doesn’t know somebody in the vulnerable populations.” Scott noted that an increase in COVID cases will have ripple effects throughout society. “When vaccination rates drop, viruses don’t just affect the unvaccinated,” he said. “They spread through schools, overwhelm hospitals, and put vulnerable people at risk. We’re setting ourselves up for preventable outbreaks.” Disease could spread without mRNA vaccine research Vaccines created through a process known as messenger ribonucleic acid, or mRNA, have been in development for decades. They work by introducing the immune system to an antigen found in a pathogen in a unique way. Instead of using a weakened or inactivated form of a pathogen, they teach the body’s cells how to temporarily produce an antigen themselves. The mRNA type of vaccine was used in COVID-19 vaccines distributed by Pfizer and Moderna. Experts note that mRNA research involves more than vaccines. “It is important to remember that mRNA technology has the potential beyond just vaccines, including personalized cancer therapy, gene editing, and treatment for genetic disorders,” Jensen said.  “A reduction in funding for mRNA vaccine development can have significant adverse effects on scientific progress in finding new innovative treatments for these varied illnesses and in helping us prepare for future emergent diseases.” When Kennedy announced the elimination of funding for mRNA research, he said it was because these types of vaccines “fail to protect” against respiratory illness. Experts disagree with the Health Secretary’s decision. “This is a half-billion-dollar decision based on fundamentally flawed science,” said Scott. “I actually read through the 181-page document Kennedy cited as justification. Most of the studies in there show harmful effects from COVID infection, which actually supports vaccination, not the opposite.” Scott added that mRNA vaccines can also be developed much more quickly than traditional inoculations. “We’re abandoning the one vaccine technology that can be updated in weeks instead of months,” he said. “When the next pandemic hits— and it will — those extra months of development time mean preventable deaths.” Fisher added that the United States should be the leader in mRNA vaccines, not the one holding up progress. “We should be leading the charge,” she said. “We don’t know what pathogens are coming.” Concerns over childhood vaccine exemptions The CDC reports that exemptions from one or more vaccines among U.S. kindergarteners increased to 3.6% from 3.3% the year before. The agency notes that vaccination coverage among U.S. kindergartners decreased for all reported vaccines from the year before, ranging from 92.1% for the diphtheria, tetanus, and acellular pertussis vaccine (DTaP) to 92.5% for the measles, mumps, and rubella vaccine (MMR) and polio vaccines. In addition, the CDC reports more than 1,400 measles cases documented in the United States so far this year. That’s the highest number in more than three decades and significantly higher than the 285 cases reported in 2024. These statistics have set off alarm bells among experts. “Higher rates of vaccine exemptions for children have several concerns,” said Jensen. “One is when exemption rates increase, herd immunity weakens, making it easier for the disease to spread.” Scott is concerned about the clusters of cases in certain communities across the country. “The geographic clustering is the real danger,” he said. “These aren’t isolated families – they’re concentrated communities where measles or whooping cough can tear through unprotected children. We’ve seen it happen before and we’re setting up for it to happen again.” “I am concerned that increasingly some parents are seeking exemptions for vaccinations of their children,” added Schaffner. “We do not want to go back to the ‘bad old days.’ These diseases were much worse than many today believe,” he told Healthline. How to stay healthy if you can’t get a COVID shot COVID-19 symptoms usually resolve without medical intervention. Some ways to reduce discomfort caused by symptoms include: rest plenty of fluids over-the-counter pain relievers and fever reducers If your symptoms persist, you should see a healthcare professional for treatment. They may prescribe the antiviral therapy Paxlovid. Experts say there are also ways to reduce your risk of contracting COVID-19, whether you’ve been vaccinated or not. “Good sleep, good nutrition, exercise regularly,” said Fisher. “These help keep your immune system in good shape. Wash hands or use hand sanitizer frequently. Finally, use masks when in public spaces with a lot of people and definitely during travel to try to avoid viral infections.”

Eating a Mediterranean diet and following a healthy lifestyle can be very effective in lowering diabetes risk. Ivan Solis/Stocksy United A Mediterranean diet, combined with calorie reduction and exercise, reduced the risk of type 2 diabetes by 31%. In a study of older adults, those who followed this lifestyle lost an average of 3.3 kilograms (just over 7 pounds) of body weight. Experts say that even small changes towards a healthier diet and more exercise can be beneficial in reducing type 2 diabetes risk Eating a calorie reduced Mediterranean diet together with lifestyle changes can reduce the risk of developing type 2 diabetes by 31%. Researchers in Spain found that following this eating pattern, participating in moderate exercise, and having professional weight loss guidance could be highly effective prevention tools against diabetes. The findings were published on August 26 in Annals of Internal Medicine. “Diabetes is the first solid clinical outcome for which we have shown — using the strongest available evidence — that the Mediterranean diet with calorie reduction, physical activity and weight loss is a highly effective preventive tool,” Miguel Ángel Martínez-González, professor of Preventive Medicine and Public Health at the University of Navarra, adjunct professor of Nutrition at Harvard University, and one of the principal investigators of the project said in a press statement. “Applied at scale in at-risk populations, these modest and sustained lifestyle changes could prevent thousands of new diagnoses every year. We hope soon to show similar evidence for other major public health challenges,” Martínez-González continued. About the research For the study, researchers followed 4,746 people ages 55 to 75 who lived with overweight or obesity as well as metabolic syndrome for six years. The participants had no prior history of diabetes or cardiovascular disease. To determine whether a Mediterranean diet with reduced calories could be beneficial in preventing type 2 diabetes, the researchers split the participants into two groups. The first group had a moderate exercise plan and professional guidance, and ate a calorie-reduced Mediterranean diet with about 600 calories less than the second group, who just ate a regular Mediterranean diet with no exercise plan or calorie reduction. As well as reducing the risk of type two diabetes, the researched found that those in the first group who ate a calorie reduced Mediterranean diet and exercised lost an average of 3.3 kilograms or 7.3 pounds of body weight. They also had a reduction of 3.6 centimeters (1.4 inches) in their waist circumference. In comparison, the second group lost 0.6 kg (1.3 pounds) and just 0.3 cm (0.1 inches) of waist circumference. This suggests the calorie reduced Mediterranean diet together with exercise prevented roughly three out of every 100 participants in the study from developing type 2 diabetes. A meaningful reduction in diabetes risk Experts say that while the dietary and lifestyle modifications in the study aren’t new, the results are promising. “31% is a substantial and meaningful reduction” said Marilyn Tan, MD, an endocrinologist and clinical associate professor of medicine at Stanford. “It’s not surprising, per se, but I would call it encouraging. We’ve known for a long time that a cleaner, less processed diet, reduced calories, and more exercise contribute to better metabolic health. In addition, professional support for weight loss is helpful not only for education but also for keeping people on track,” Tan told Healthline. More than 38 million Americans live with diabetes, and of these, 90-95% live with type 2 diabetes. Rates of young people developing diabetes are also rising. “In the U.S., prevalence and incidence of diabetes are tied to body weight and obesity (higher than global average), dietary quality (which is lower than the global average), and physical activity (which is also very low with people in sedentary jobs and doing a lot of commuting to and from work),” Dana Hunnes, PhD, senior dietitian supervisor at the RR-UCLA Medical Center told Healthline. “Also, our healthcare system is not equal for all. Many people cannot afford healthy food, good health care, and depend on ‘what seems like inexpensive’ foods that cause a lot of health problems in life. So, this is sadly very concerning, and there are [multiple] factors that are responsible for these trends,” Hunnes noted. Lifestyle changes help prevent diabetes Lifestyle changes can prevent or delay type 2 diabetes, and experts say both exercise and the Mediterranean diet are useful change people can implement. “The Mediterranean diet emphasizes whole grains, vegetables, fruits, legumes and nuts; overall this is reducing carbohydrate and sugar intake which in turn reduces insulin secretion and increases fat breakdown, both improving diabetes risk,” said Mir Ali, MD, board certified general surgeon, bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, California. “I suggest to my patients to start with small changes, like eliminating sugary drinks, and build on improving the diet from there. Also, with exercise, it is more important to be consistent (30 minutes/day, 5 days a week) than having irregular intense exercise, and even walking is beneficial. If it’s not possible to get in the exercise in one session, breaking it up throughout the day is acceptable. Again, starting with small changes and building on that,” Ali said. Barriers to healthier food choices Whilst the Mediterranean diet and lifestyle interventions in the study show significant benefit, Tan notes that there may still be barriers for some. “For many people, it may be difficult to implement. In general, healthier whole foods, olive oil, healthy nuts, fruit, etc., are more expensive than processed foods,” Tan said. “It also takes time to buy and prepare these foods, and many people don’t have time for the meal preparation. Physical support for weight loss is not always available locally or covered by insurance. In addition, most people are aware that physical activity is important, but this also relies on having time and a safe place to exercise,” she continued. In the study, the reduced-calorie group ate 600 fewer calories than their peers. The experts note that while tracking and reducing calories can seem overwhelming, some strategies can make it more manageable. “One way to start is by reducing portion size,” Ali said. “Some people will get smaller plates or use other guides to help reduce portions. Others will use apps or other methods to help reduce calories. Again, it is easier to make small changes that are sustainable and build on those changes. Unfortunately, no one method works for every person.” There are some risk factors for type two diabetes that can’t be changed, like age or having a family history of diabetes. But experts say weight loss can still make a notable difference to reducing risk. “Weight loss in someone who is overweight or obese can help reduce diabetes risk significantly,” Tan said. “It’s been established that a 5–10% weight reduction in someone who is overweight or obese can reduce type 2 diabetes risk.”

From hair growth supplements to prescription medications, experts discuss the best treatments for female hair loss. Manassanant Pamai/Getty Images Women may experience hair loss for many reasons, including genetics, stress, and aging. Certain home remedies may provide modest benefits for hair health, but many lack scientific evidence. A dermatologist can recommend the most effective medications and treatments for female hair loss. Noticing more hair on your pillow, in the shower, or on your brush can be a stressful experience for anyone. While losing around 50 to 100 strands of hair each day is completely natural, when hair loss is more than normal, it can spark anxiety about whether there is a health issue happening beneath the surface. From kitchen remedies and essential oils to massages and nutritional supplements, countless solutions promise thicker, healthier hair for women, yet it’s hard to know what really works. At the same time, medical treatments exist for cases where hair loss is more than cosmetic, but figuring out when and how to seek professional help isn’t always straightforward. If you’ve ever wondered what causes female hair loss, whether home remedies actually make a difference, or when it’s time to call your doctor, our experts will help you separate myth from reality. What are some common causes of female hair loss? Susan Massick, MD, a board certified dermatologist at The Ohio State University Wexner Medical Center, told Healthline there are several common causes of hair loss in women. Androgenic alopecia, also known as female pattern hair loss, is a hereditary condition where the hair follicles shrink and stop growing hair. In women, this type of hair loss occurs “mainly on the vertex of the scalp, although some women do note thinning along the frontal hairline, particularly near the temporal scalp,” she said. Massick explained that there are also certain medical conditions that can cause hair loss, including: Thyroid disease, including both hyperthyroidism (overactive thyroid) and hypothyroidism (underactive thyroid) Nutrient deficiencies, such as low iron, protein, zinc, or biotin Autoimmune conditions, like alopecia areata, lupus, and lichen planopilaris, in which the immune system begins to attack hair follicles, causing hair to fall out Polycystic ovarian syndrome (PCOS), a condition in which women develop small cysts on their ovaries as well as hormonal imbalances Anything that stresses the body can lead to a type of hair loss called “telogen effluvium,” in which there is rapid, all-over shedding of hair, she added. High fevers, severe infections, surgeries, childbirth, rapid weight loss, and psychosocial stressors from work or home life are all potential causes of telogen effluvium. Certain medications and chemotherapy can also be culprits in hair loss, Massick said. She further pointed out that the normal hormonal shifts that women experience throughout their lifespan, such as pregnancy, childbirth, and menopause, may cause hair shedding. Massick additionally noted the impacts of hairstyling techniques, explaining that traction alopecia can occur, especially along the front hairline, when women wear tight braids, use heat styling methods like flat-ironing, or use chemical treatments like perms, dyes, and relaxers. How effective are home remedies for hair loss? Marie Jhin, MD, a board certified dermatologist and the Chief Medical Officer at Musely, said that natural remedies can help support hair and scalp health, but their results are usually modest. “Coconut oil, for example, can strengthen strands and reduce breakage, but it is unlikely to spark new growth,” she said. “Rosemary and peppermint oils may boost circulation to the scalp, but studies are limited.” Jhin said that red ginseng and onion juice have shown some benefit in small studies, but are not considered to be reliable treatments on their own. “Scalp massage can temporarily increase blood flow, which may feel soothing but will not reverse significant thinning,” she added. Jhin noted that while these natural remedies may complement proven medical therapies, they cannot replace a visit to a dermatologist. Massick added that it’s important to be gentle in your haircare routine and eat a well-balanced diet. She suggested taking care of any health or lifestyle factors that might be contributing to your hair loss. “[Have] your thyroid, hemoglobin (i.e., blood counts), and iron/ferritin levels checked; manage stress; no smoking; get plenty of rest,” she advised. What hair loss treatments are available? Massick said the first thing to know about treating hair loss is it’s “a marathon, not a sprint.” She suggests being patient and being realistic about the fact that it may take six months or more to see results. She additionally discussed the following treatment options available through your dermatologist. Medications Minoxidil (Rogaine) When it comes to medications, she said minoxidil, in both topical and oral forms, may be used to combat thinning hair. “Although the exact mechanism of action is unknown, it is thought that improved blood flow to the hair follicles prevents hair shedding and perhaps enhances hair regrowth,” she explained. According to Massick, minoxidil has some pluses: It has been widely studied and clinically proven to slow hair loss. It is easy to use and generally considered safe. It can also be obtained over the counter or by prescription. However, it does have some downsides. It must be used consistently; you will lose any gains if you stop using it. Additionally, it can take a minimum of six months for women to see improvement. Also, it is not safe for those who are or may be pregnant or who are nursing. Finasteride (Propecia) This drug is often used to treat enlarged prostates in males as well as male pattern hair loss. While the Food and Drug Administration (FDA) has not approved it for use in women, Massick said some doctors may consider its use, in both topical and oral forms, for female-pattern hair loss. However, finasteride is only considered to be appropriate for those who are postmenopausal or otherwise unable to bear children. Finasteride inhibits type II 5-alpha-reductase, the enzyme that converts testosterone into dihydrotestosterone (DHT). “By blocking the conversion of testosterone to DHT, finasteride prevents the miniaturization of the hair follicles, arresting the hair loss,” explained Massick. Although this medication is convenient to use — it can be taken as a once-a-day pill—and it’s clinically proven to stop hair loss and even sometimes induce hair regrowth, it also works only as long as you are using it and may not work well for everyone. Its potential to cause birth defects in male babies also limits its use in women of childbearing age. Dutasteride (Avodart) According to Massick, oral dutasteride inhibits both type I and type II 5-alpha-reductase enzymes. Because of this dual inhibition, “[It] appears to hold a slight advantage over finasteride in limiting or even reversing hair loss,” she said. However, it comes with the same concerns as finasteride and is not currently FDA-approved for hair loss; it is only approved for treating benign prostatic hyperplasia (BPH) in males. This means any use in women for hair loss is off-label and should be limited to those who can’t become pregnant while using it. It also has a longer half-life, so it will remain in the body longer than finasteride. Spironolactone Massick said spironolactone has anti-androgen effects, making it useful for female pattern hair loss, especially in women with PCOS who may have excess male hormones. Again, however, it is not advised for pregnant and breastfeeding women due to possible birth defects in male babies. It should also be noted that spironolactone is a diuretic, so it can affect blood pressure. If it lowers your blood pressure too much, this may be a concern. Women with kidney disease or high potassium should also not use it since it may increase potassium to dangerous levels. Platelet-rich plasma (PRP) Platelet-rich plasma (PRP) treatments are performed by drawing blood, spinning it down to separate out the different components, and injecting the concentrated platelet-rich plasma into the treatment area. “PRP treatments use your own plasma to help induce hair growth,” Massick explained, noting that PRP is used for androgenic alopecia since it concentrates growth factors to stimulate the hair follicles. While this treatment can be effective, it works better when used with other hair loss treatments. However, it is expensive and the results are temporary, so the procedure must be repeated periodically. Additionally, the FDA has not approved PRP as a treatment for hair loss. “Generally, patients undergo injections every 4 weeks for 3 months and then maintenance when needed,” Massick said. Low-level laser therapy (LLLT) Low-level laser therapy (LLLT) involves stimulating hair growth with red light at 655 nanometers. “Although the exact mechanism of action is not fully known, the thought is that the light will activate stem cells in the hair follicles, thus regenerating from a dormant to the growth phase of the hair cycle,” said Massick. She said there are several devices on the market, available as both combs and helmets/caps. “Results vary among patients and depend on consistent usage,” said Massick, “with best results typically when used in combination with other modalities, such as topical minoxidil.” Hair transplant Massick said she would recommend a hair transplant only if all other options had failed. Explaining the procedure, she said that micrografts of one to two units are harvested where normal hair is growing and are then transplanted into the thinning area. Cons of hair transplantation, per Massick, are that it is painful, costly, and requires a recovery period following surgery. When should you see a doctor for hair loss? Jhin said, “If hair loss comes on suddenly, worsens quickly, or appears in patches, it is best to see a dermatologist right away to rule out underlying medical conditions.” She further advised that if you’ve been using over-the-counter hair loss treatments without much success, this would also be a good time to seek out professional care. “The sooner treatment starts, the better the chances of preserving and restoring hair,” said Jhin. You can find a dermatologist near you using Healthline’s FindCare tool.

Serena Williams recently shared her weight loss journey with the GLP-1 medication Zepbound. Joe Buglewicz/Getty Images for International Tennis Hall of Fame Serena Williams recently announced that she lost 31 pounds after taking the GLP-1 drug Zepbound. The tennis legend began taking the weight loss medication after having her two children. Williams shared that regular exercise and healthy eating are a part of her weight loss journey. Serena Williams is opening up about her weight loss journey with GLP-1 medication Zepbound. The former professional tennis player is among other celebrities like Oprah and Kelly Clarkson who’ve shared their weight management stories and why they turned to medication. Williams, a 23-time Grand Slam champion, told Elle magazine that after having her second child in 2023, she lost weight within two weeks, but no matter what she did after that, she couldn’t lose more. “Every single day, I would get my 30,000 steps. I ran and trained. Even after my first daughter, I never got back to the level that I wanted to be,” Williams told Elle. The weight she carried caused her to experience joint pain when she played tennis, she told Women’s Health. Williams began taking a GLP-1 medication in the summer of 2024 but decided to stop. Then, in January 2025, she teamed up with the telehealth company Ro, which her husband, Alexis Ohanian, is an investor in and board member of, to receive Zepbound. In a Ro-sponsored Instagram post, Williams said she lost 31 pounds while taking Zepbound. She joins former NBA star Charles Barkley, who lost 65 pounds taking a GLP-1 in partnership with Ro. “Serena Williams is such an inspiration to so many, and I’m glad to hear she has spoken about this publicly. It’s an important message,” Scott Isaacs, MD, president of the American Association of Clinical Endocrinology, told Healthline. Williams faced scrutiny about her body Williams has faced scrutiny around her body her entire life. In her HBO documentary, “Being Serena,” one scene shows her coach talking with her about the need for her to lose weight. Fans have also commented on her body throughout the years, expressing both positive and negative sentiments. While Williams said she put a lot of thought into taking anti-obesity medication, she told Vogue that at this point in her life, she doesn’t feel ashamed about letting the public know. “For lack of a better way to say it, I don’t really care what people are saying about my body anymore. But what is important to me is transparency,” she said. Isaacs said stigma around obesity can make people feel judged or guilty for using medication to manage their weight. “Many patients blame themselves, even though obesity is a disease of disordered appetite and biological origin, not simply the result of habits or willpower,” he said. “Weight is determined primarily by biology and genetics, not by willpower alone.” But taking anti-obesity medications isn’t the “easy way out,” said Rekha B. Kumar, MD, senior medical advisor at Cornell University and chief medical officer at Found. Kumar noted that as more high-profile people share their experiences, the stigma around these medications will soften. “People who have all the tools in the world, like Serena and Oprah, have shown us that this is not the easy way out but rather an important tool to address the biology of weight control when diet and exercise do not help,” Kumar told Healthline. What to know about Zepbound Zepbound (tirzepatide) is currently the most effective medication available for weight management. “Tirzepatide works by targeting both GLP-1 and GIP receptors, resulting in greater weight loss and better glucose lowering than medications that target GLP-1 alone,” said Isaacs. In the head-to-head SURMOUNT trial, funded by drug manufacturer Eli Lilly, people who took tirzepatide lost more weight than those who took semaglutide (Ozempic). After 72 weeks of treatment, participants taking tirzepatide lost 20.2% of their body weight (about 50.3 pounds), while those taking semaglutide lost 13.7% (about 33.1 pounds) of their body weight. “All GLP-1s are excellent medicines for diabetes and weight control. We often are limited by what insurance covers and occasionally will look at other comorbidities that a medicine is approved for to see if they might be a good fit,” said Kumar. Isaacs reiterated that insurance coverage is a big determining factor for GLP-1 access. He pointed to CVS Caremark’s recent change. As of July 1, it removed Zepbound from its formulary, which required most patients to switch to Wegovy, regardless of which drug works better for them. “Even if a patient is doing well on a medication, insurance sometimes forces a switch due to coverage restrictions or deals made behind the scenes,” Isaacs said. “Cost, patient preference, and side effects still matter, but they are all secondary to what the insurance will actually pay for.” Is Zepbound or Wegovy right for you? Zepbound is for adults with obesity or overweight who also have weight-related health conditions such as type 2 diabetes, cardiovascular disease, or high blood pressure. Zepbound is also indicated for people with moderate to severe obstructive sleep apnea and obesity. Tirzepatide is helpful for people with metabolic dysfunction-associated steatohepatitis or nonalcoholic steatohepatitis (NASH, formerly MASH). “In the SYNERGY-NASH trial, tirzepatide showed significant rates of MASH resolution, up to 62%, compared to 10% with placebo, and improved fibrosis in over 50% of participants,” said Isaacs. Semaglutide (Wegovy) recently became the first GLP-1 approved by the FDA to treat adults with MASH with moderate-to-advanced fibrosis, based on the phase 3 ESSENCE trial. “Both medications treat obesity and many related metabolic conditions,” Isaacs said. Tirzepatide and other GLP1s work by targeting specific biological and hormonal pathways that regulate appetite, cravings, and weight. “Needing medication for weight is no different than needing it for diabetes or blood pressure, and by treating excess weight, many related medical issues can improve,” said Isaacs. “Choosing to treat obesity is a choice for health, not a sign of weakness. Doing nothing is actually the easier path, but taking action shows real strength.” GLP-1s works best when combined with healthy habits Williams’ Instagram feed shows that she continues to exercise a lot and eat healthy while taking Zepbound. She told Vogue that she gets her protein fill from beans. According to Kumar, she is taking the right actions. “[Zepbound] is a power tool, and patients need to consider what they are willing to change in their lifestyle because if protein requirements and strength training are not in place, people can lose muscle and be predisposed to regaining fat mass if they stop the medicine,” she said. Anyone considering or taking tirzepatide should know that it works best when combined with regular exercise and a balanced, low calorie diet, said Isaacs. “Medications are an important option when lifestyle changes alone are not enough, but they do not replace the need for healthy living,” he said. “Tirzepatide is a medical therapy, not a quick fix, and it requires ongoing medical supervision.” Side effects, most often nausea, vomiting, diarrhea, or constipation, are common, especially as the dose increases. “Some people are ‘super-responders’ and achieve great results with very low doses known as micro-doses, while others may need to titrate up to the highest dose to get the desired effect,” said Isaacs. He added that most people need to continue tirzepatide long term because there is a high risk of weight regain if the medication is stopped. “Everyone’s response is different, so an experienced physician should manage titration and help address any side effects,” he said. Obesity experts can also inform you about newer medications that are transforming obesity care. Isaacs said more GLP-based medications are on the horizon, including new injectables and lower-cost oral versions expected in the coming years. “We are truly moving into a new era where obesity is managed like any other chronic medical condition, offering hope and effective therapies,” he said. Learn more about how to get GLP-1 medications from vetted and trusted online sources here: Where to Buy Ozempic Online Where to Buy Ozempic Online How to Get Mounjaro (Tirzepatide) Where to Buy Mounjaro (Tirzepatide) Online How to Get Wegovy for Weight Loss In Person and Online How to Get a Wegovy Prescription Online How to Get Zepbound: What We Know So Far Where to Buy Zepbound Online

Anecdotal reports of “Ozempic vulva” include unusual vaginal changes as a possible side effect of GLP-1 drugs. Liudmila Chernetska/Getty Images Women are reporting what’s been coined as “Ozempic vulva,” an unexpected side effect of Ozempic and other GLP-1 drugs. Ozempic vulva is characterized by sagging skin, vaginal dryness, and weaker pelvic muscles.  Experts say sagging skin is likely a side effect of rapid weight loss, rather than the weight loss drug itself. Pelvic floor physical therapy, vaginal lubricants, and topical estrogen may help with symptom management. Ozempic and other GLP-1 medications are fast becoming household names for their role in weight loss. Their side effects are making headlines, too.  Alongside well-known side effects like nausea, constipation, and stomach pain, some users are reporting a more unexpected concern: “Ozempic vulva.”  Online, females are sharing changes they’ve noticed since they started taking GLP-1 injections, including sagging skin, vaginal dryness, weaker pelvic muscles, and, in some cases, increased discharge.  “I’ve lost 20 kg or 44 lbs. I’ve been really lucky, and I have no noticeable sagging skin in my tummy or my arms/legs. Then I went to the gyno today cause I was experiencing pain when biking and sitting for long periods,” one woman shared on Reddit.  “Turns out I’ve lost all my fat pads in my vulva! She told me my vulva is saggy and I will continue to experience pain when biking/sitting,” she continued.  While vaginal changes aren’t a listed side effect of GLP-1 medications, experts suggest that rapid weight loss and the loss of fat pads that support vulvar tissue may play a role in these symptoms.  Is ‘Ozempic vulva’ a real side effect of GLP-1 drugs?  “Ozempic vulva is not a medical term, nor is it a direct side effect of GLP-1 medications,” Prabha Sivaraman, consultant obstetrician-gynecologist at Manchester Deansgate Clinic, United Kingdom, told Healthline.  “What women are noticing is actually the impact of rapid weight loss on soft tissues. The medication itself does not act on the vulva, vagina, or pelvic floor, and the changes are really byproducts of body composition shifting quickly.” When rapid weight loss occurs, fat pads in the vulva can shrink. This may be particularly noticeable in the mons pubis and labia majora, which provide volume and shape. “If skin elasticity and connective tissue don’t adapt at the same pace, the result can be a looser or less supported appearance,” Sivaraman explained.  “It’s essentially the same mechanism we see elsewhere in the body. When weight drops rapidly, the skin and tissues sometimes lag behind.” Daniel Atkinson, a general practitioner and clinical lead at Treated, United Kingdom, told Healthine that it’s important to remember weight loss looks different on everyone.  “People have little control about which parts of their body are affected,” he pointed out. “The vulva contains fatty tissue, so its appearance and elasticity could potentially change when someone loses weight, in the same way certain other areas of the body might look and feel different.”  Other symptoms include vaginal dryness, muscle weakness  Sagging skin isn’t the only reported side effect of GLP-1 medications. Some women also report experiencing vaginal dryness and muscle weakness.  Sivaraman said neither dryness nor pelvic muscle weakness is caused by GLP-1 medication itself. “Vaginal dryness is almost always hormonal and could be due to menopause or contraceptives,” she explained.  Muscle weakness, including in the pelvic floor, can occur if weight loss is accompanied by loss of lean muscle mass.  “Without resistance training and adequate nutrition, some muscle strength is inevitably lost. These are consequences of rapid weight and body composition changes, not of the drug directly,” Sivaraman said.  Should you be concerned about sagging skin?  If you’re experiencing any of these side effects, when are they a cause for concern?  Atkinson said it’s a good idea to start with a visual check.  “It’s worth considering these changes might occur for other reasons too, such as hormonal changes, other medications, or even genetics,” he shared.  “However, if you experience vaginal irritation and discomfort you think is happening because of your treatment, you should speak to your prescriber right away.”  Cosmetic differences like sagging skin aside, Sivaraman said there are other changes to be mindful of.  “Concern arises if new symptoms develop, such as urinary leakage, pelvic heaviness, bulging, or painful dryness.  “Those symptoms may point to pelvic floor issues or hormonal changes, and they are worth seeking medical advice about because effective treatments are available,” she explained.  Treatments and therapies for ‘Ozempic vulva’ If you’ve experienced rapid weight loss and are navigating vaginal changes, some treatment options are available. “Surgery is not the first line of management and should be considered only if symptoms are severe or persistent,” Sivaraman advised.  There are many supportive measures, many of which you can try at home.  “Pelvic floor physiotherapy and exercises such as Kegels strengthen support and reduce symptoms of laxity,” said Sivaraman.  “Meanwhile, vaginal moisturizers and lubricants help with dryness, and topical estrogen is highly effective in postmenopausal women if suitable.”  Adjusting your approach to weight loss may prove useful, too. “Maintaining gradual, well-paced weight loss and incorporating resistance training protects tissues and muscle tone,” Sivaraman noted. If your discomfort persists, your clinician can offer advice on how to manage it and help you determine if your weight loss treatment is the cause.  Sivaraman said these changes are not unique to GLP-1 medications like Ozempic.  “Any method of significant weight loss, whether through bariatric surgery, strict dieting, or medication, can cause them,” she explained.  “What makes the difference is the speed and scale of weight loss. Rapid, large reductions make changes more noticeable, while gradual weight loss gives tissues more opportunity to adapt.”

The Signos system can be used alone, in combination with, or after GLP-1 drugs or bariatric surgery. Photography courtesy of Signos The FDA cleared the first glucose monitoring system specifically designed for weight management, from startup Signos, providing a new option for maintaining a healthy weight. The system uses a continuous glucose monitor, or CGM, which sends real-time data to an app. This is coupled with an AI platform to provide personalized lifestyle recommendations for weight management. The system, which requires a monthly membership, can be used alone or with or after weight loss treatments such as GLP-1 drugs or bariatric surgery. This week, the Food and Drug Administration (FDA) cleared the first glucose monitoring system specifically designed for weight management, from California-based start-up Signos, providing Americans with a new option for maintaining a healthy weight. The system uses a glucose biosensor from Dexcom that tracks blood glucose 24/7 to reveal how food, exercise and sleep can impact glucose levels. This is paired with an AI platform to transform real-time data into personalized, lifestyle recommendations for managing weight. “Signos shows you how your body utilizes glucose as a fuel source and helps you keep an eye on your overall metabolism by spotting patterns that make weight management difficult,” Sharam Fouladgar-Mercer, CEO and co-founder of Signos, told Healthline. Glucose monitoring available to everyone The Signos system has been “cleared” by the FDA, which is different from being “approved.” When a device is cleared, the manufacturer has shown that it is “substantially equivalent” to a legally marketed device — meaning it is as safe and effective, and works in the same way. FDA approval is a stricter designation required for prescription medications, over-the-counter medications, vaccines, and Class III medical devices such as those that are implanted in the body or have the potential to cause significant injury or illness. Other treatment options for losing weight are generally limited to people above a certain body mass index (BMI) or who are overweight and have other health conditions. These include GLP-1 receptor agonists such as Wegovy and Zepbound and surgical options like bariatric surgery. However, anyone can purchase a Signos membership to access its system.  “Everyone deserves access to insights that help them live healthier, longer, more vibrant lives. Signos isn’t just about data; it’s about giving people ownership over their health and weight journeys in a way never before seen,” Fouladgar-Mercer said in a press release. Obesity costs the U.S. healthcare system almost $173 billion a year, according to the Centers for Disease Control and Prevention (CDC). Almost three-quarters of Americans are overweight, which includes those with obesity, CDC data shows. The Signos glucose monitoring system uses a glucose biosensor that tracks blood glucose 24/7. Photography courtesy of Signos System supports other weight loss treatments Customers who sign up for the Signos system can choose a three-month plan for $139 or a six-month plan for $129. Health insurance companies don’t currently cover the system for weight management, but Signos says it is working with insurers to get coverage. The Signos system can be used alone, in combination with, or after GLP-1 drugs or bariatric surgery. ”Signos is designed to help you on your weight journey, regardless of where you are in it,” Fouladgar-Mercer told Healthline. “If you are being treated with different options, having that knowledge [about your glucose levels] is powerful in many ways, including maintaining that weight loss.” The Dexcom biosensor is placed on the upper arm, and data is wirelessly sent to Signos’ app. The app also allows people to log their food intake, physical activity, and other information that the AI platform uses to make personalized recommendations. In addition to assisting people in losing weight, the Signos system helps people understand how their bodies respond to meals, exercise, sleep and stress, which can encourage them to make behavioral changes that improve their overall health. “With Signos, people form habits that stick for life,” Fouladgar-Mercer said. “Diets are generally tough to sustain, and then there’s often the rebound effect. Knowing what works for you is critical for maintaining the healthy weight you worked so hard to achieve, and our member feedback says that approach is the most effective.” Benefits of glucose monitoring Paunel Vukasinov, MD, an internist and obesity medicine specialist with Medical Offices of Manhattan and a contributor to LabFinder, told Healthline that using a continuous glucose monitor (CGM) can help patients become aware of the impact that food has on their glucose levels. “Many patients change what they eat once they see how certain foods affect their glucose,” he said, “and they say the tool helps them make healthier choices overall.” However, “for people without glucose issues, CGMs may add little benefit beyond what general healthy eating advice provides,” he cautioned. So “the data should always be interpreted with a trained healthcare professional for optimal results.” Some research suggests that continuous glucose monitoring can motivate people to change their behaviors, although larger, more rigorous studies are needed. One small study looked at sedentary individuals with overweight or obesity. People received one-on-one counseling to learn how physical activity affects blood glucose levels. They then used a CGM or an activity tracker for 10 days. Afterward, both groups reported being more motivated to exercise. Fouladgar-Mercer said the company plans to publish data in the future around the effectiveness of their system for weight management. “That said, all of our data, as well as a plethora of other research, has shown that managing glucose is critical to managing your weight,” he said. “It’s fundamental. And Signos is [currently] the only system that focuses on that aspect.”

New blood pressure guidelines from the AHA recommend starting treatment earlier and abstaining from alcohol. Maskot/Getty Images New blood pressure guidelines from the American Heart Association (AHA) reaffirm earlier recommendations and include some key changes. The new guidelines recommend earlier treatment for high blood pressure and abstaining from alcohol. They also emphasize the dangers of hypertension during and after pregnancy. New blood pressure guidelines issued by the American Heart Association (AHA) and American College of Cardiology call for earlier treatment, abstaining from alcohol, and greater attention to blood pressure during pregnancy, among other changes. High blood pressure or hypertension is the most prevalent modifiable risk factor for the development of cardiovascular disease. Hypertension affects about half of U.S. adults, putting them at greater risk of heart attack, stroke, and dementia. Despite being widespread, hypertension is typically asymptomatic and under-treated; only about one in four adults with high blood pressure has it under control  The latest guidelines are largely unchanged from the 2017 version, published nearly a decade ago. The core recommendation remains intact: adults should achieve a blood pressure of less than 130/80 mm HG. They also continue to emphasize the importance of diet, salt intake, and weight loss as modifiable lifestyle changes that can help achieve this goal.  But there are also important changes and updates too, namely earlier and more aggressive treatment of hypertension.  “For the vast majority of people, the advice provided in the 2017 guidelines still holds,” said Randall S. Stafford, MD, PhD, a professor of medicine and director of the Program on Prevention Outcomes and Practices at Stanford Medicine. Stafford was also a member of the AHA’s hypertension guideline committee in 2017. “These updated guidelines suggest more intensive treatment of high blood pressure in the presence of hypertension-related disease. The intensity of treatment is slightly greater for people with chronic kidney disease, coronary artery disease, diabetes, and a high risk of future cardiovascular events like stroke and heart attack,” Stafford told Healthline. Here are the main takeaways from the new guidelines, as well as actionable steps you can take to lower your blood pressure. Earlier treatment for hypertension The categories of blood pressure did not change this year, but when to seek treatment has. The stages of hypertension are classified as: Normal: less than 120/80 mm/Hg Elevated: 120–129 / less than 80 Stage 1 Hypertension (High Blood Pressure): 130–139 or 80–89 Stage 2 Hypertension (High Blood Pressure): 140 or higher or 90 or higher Severe Hypertension: higher than 180 and/or higher than 120 Hypertensive Emergency: higher than 180 and/or higher than 120 Earlier guidelines recommended treatment with lifestyle changes and medication for people with blood pressure readings above 140 mm Hg, classified as stage 2 hypertension. The new guidance lowers that threshold to include those with readings in the 130–139 mm Hg range, or stage 1 hypertension. Doctors are expected to start with lifestyle changes for three to six months. If blood pressure remains above target after that period, medication may be added. Alongside this change, the guidelines also recommend the use of the PREVENT risk calculator, to help with early detection of cardiovascular disease. The calculator is “the first risk calculator that combines measures of cardiovascular, kidney, and metabolic health” to estimate cardiovascular disease risk and guide personalized treatment. The authors also now emphasize the role of hypertension in the development of dementia later in life as part of this shift towards earlier treatment. “There is now more clear and robust evidence that intensive lowering of blood pressure reduces the risk of cognitive decline and dementia,” Daniel W. Jones, MD, FAHA, volunteer chair of the guideline writing committee and a past-president of the AHA (2007-2008), told Healthline. Alcohol — no safe amount for heart health In another shift, the guidelines now recommend minimal — ideally zero — alcohol consumption. “These new guidelines make clear that when it comes to alcohol consumption, less is more. In fact, the data that informs these guidelines suggest that eliminating alcohol intake altogether may have the most favorable impact on blood pressure, particularly for patients with existing hypertension,” said Daniel Muñoz, MD, MPA, executive medical director of the Vanderbilt Heart & Vascular Institute, Vanderbilt University Medical Center. Muñoz wasn’t involved in the new guidelines. For those who do choose to drink alcohol, the current recommendation is no more than two drinks per day for males and no more than one drink per day for females. Despite this, Stafford noted that “there is no safe level of alcohol exposure.” Reducing sodium is still key Limiting dietary salt (sodium) consumption remains a pillar of hypertension prevention. Although unchanged, the latest guidelines reinforce earlier recommendations of limiting sodium intake to less than 2,300 milligrams per day, with an ideal goal of just 1,500 mg (about ¾ of a teaspoon) per day. “The new guidelines make clear the importance of moderating and limiting the amount of dietary sodium intake, given the clear linkage between excess sodium intake and high blood pressure,” Muñoz said. Although managing salt intake can be challenging, experts recommend a few simple tactics, such as: selectively using potassium-based salt substitutes specifying less or low salt when dining out reading nutrition labels and avoiding high sodium foods skipping the salt shaker at mealtimes Hypertension and pregnancy If you are pregnant or plan to become pregnant, you need to “know your numbers.” High blood pressure during pregnancy can lead to serious complications, including preeclampsia, stroke, kidney problems, and premature delivery.  “The guidelines include important new recommendations for how to treat blood pressure during pregnancy, including an emphasis on the importance of monitoring blood pressure during the post-partum period. High blood pressure during or after pregnancy can endanger the health of the mother and can also impact the health of the child,” Muñoz said. “Thankfully, we know that effective treatments exist for controlling blood pressure during and after pregnancy,” he added. Modest weight loss can improve heart health The Dietary Approaches to Stop Hypertension (DASH) diet is a standard recommendation for lowering blood pressure and improving heart health. “The DASH diet is a well-proven tactic for blood pressure management. It is well-balanced and rich in nutrients, including from fruits, veggies, [and] whole grains. It’s also low in salt and low in saturated fats, all of which contributes to better cardiovascular health,” said Muñoz. Additionally, other lifestyle factors, including exercise and weight loss are important contributors to lowering blood pressure and greater overall cardiovascular health. The guidelines recommend the standard target of 150 minutes per week of moderate exercise. They also highlight that even moderate weight loss of 5% body weight is enough to achieve health benefits and improve blood pressure. “Excess weight puts excess strain on the heart and excess load on our blood vessels. By losing weight, we reduce this strain and allow our cardiovascular system to operate at its best. I’ll also add that it’s best to lose weight in safe, sustainable ways, especially through a healthy diet and regular exercise,” Muñoz said. The guidelines also acknowledge GLP-1 drugs and bariatric surgery as effective weight loss interventions that also aid in lowering blood pressure. While there are no major overhauls of the general recommendations this year, the updates do provide timely, up-to-date information about the most important steps individuals can take to reach their blood pressure goals. The guidelines are also a reminder that although high blood pressure is pervasive, it is also highly treatable. “It is often referred to as ‘the silent killer‘ because there are no symptoms of high blood pressure for a lot of people. This latest information will help people to make wise and informed choices about reducing their risk of heart disease, stroke, dementia, and chronic kidney disease by managing their blood pressure through lifestyle therapy and medication, if appropriate,” Jones said.

A new study found that OTC birth control has significantly expanded access to a safe and reliable birth control method. Carol Yepes/Getty Images In 2023, the FDA approved Opill, the first over-the-counter oral contraceptive that became widely available at in-person and online pharmacies. Researchers examined whether Opill increased birth control access and found that the pill has helped more women to begin or improve their birth control. Experts say access to birth control is especially important as access to safe and legal abortion remains restricted in many parts of the U.S. In 2023, the Food and Drug Administration (FDA) approved the first over-the-counter (OTC) oral contraceptive pill, Opill, paving the way for improved birth control access without a prescription. Opill is a progestin-only oral contraceptive that does not contain estrogen. The once-daily pill is 98% effective at preventing pregnancy when used exactly as directed and 91% effective with typical use.  This form of birth control works by thickening cervical mucus, preventing the sperm from reaching the egg. It may additionally stop the egg’s release from the ovary. For the first time, a large study highlights the impact of Opill by examining whether access to an over-the-counter birth control option has improved since its FDA approval. According to researchers at Oregon Health & Science University, there is good news: Opill reached many people who previously did not use any contraception or relied on less-effective methods. The findings were more pronounced among underserved populations such as uninsured people, adolescents, and those living in rural areas. The results of this nationally representative study were published on August 18 in JAMA Network Open. Opill increased birth control pill access The research looked at nearly 1,000 people ages 15 to 45 in 49 states who received oral contraceptive pills between April 2024 and February 2025. About one-third of this group purchased over-the-counter birth control through either a large pharmacy chain or through Opill’s online retailer. Two-thirds of subjects obtained a prescription from a healthcare professional. Compared with prescription users, those who used OTC birth control pill were more likely to: be uninsured (32% vs. 4%) live in rural areas (14% vs. 8%) be adolescents ages 15 to 20 (14% vs. 7%) identify as Black or Latina have lower levels of formal education reside in Southern states As the study authors note, these groups are more likely to face obstacles to obtaining a prescription for contraception. Those who used OTC birth control were also more likely to have been pregnant or given birth before. They reported having sex more often but were less likely to have received contraceptive counseling in the past year. Many were not using a current birth control method before obtaining the OTC birth control pill, or they relied on less effective methods like condoms or emergency contraception. By contrast, prescription users were more likely to already be using highly effective methods The biggest impact of expanded OTC birth control access, however, was in helping people start or upgrade their contraception: Among those not using any modern method before, 42% of OTC birth control users started the pill, compared with only 11% of prescription users. Among those previously using less effective methods, 49% of OTC birth control users switched to the pill, compared with 8% of prescription users. In other words, people who might otherwise go without reliable contraception were much more likely to begin or improve their birth control use when the pill was available over-the-counter. Why expanded access to birth control matters Carly Ross, MD, an OB-GYN and Winx Health advisor specializing in patient advocacy and accessibility, said that access to contraception is essential. “With reproductive rights facing increasing restrictions, prevention is more important than ever,” she told Healthline. “We’re seeing women lose autonomy over their bodies while simultaneously facing reduced access to comprehensive reproductive care — with nearly 19 million women living in reproductive care deserts.” Ross added that birth control is about more than just pregnancy prevention. “[It] gives women the power to plan their futures, their careers, and their families on their terms,” she said. “When accurate information about our bodies is being erased from public websites and over a third of states don’t require medically accurate sex education, we’re setting people up to make uninformed decisions about their health,” she noted. Increasing accessibility, whether that’s through OTC birth control pills or other types of reproductive healthcare, is crucial for empowering women in their healthcare choices, Ross said. How to locate OTC birth control pills In addition to pregnancy prevention, hormonal contraception can also help with the management of certain chronic health conditions, including endometriosis. If you’re interested in learning more about the best form of birth control to suit your needs, talk with your doctor. If you make an informed decision that doesn’t require a prescription, OTC birth control is widely available at large chain pharmacies and big-box retailers. Sadia Saeed, MD, a physician at Welzo, noted that many of these retailers provide online ordering for in-store pickup or delivery. “In areas where local access is limited, reputable online pharmacies and telehealth services can ship directly to your home,” Saeed told Healthline. If you do go this route, however, Saeed cautioned that you should ensure you’re obtaining OTC birth control from a licensed retailer that carries only FDA-approved products. You can also ask your pharmacist before you make your purchase. Even though these medications are OTC, a pharmacist can still provide invaluable information, Saeed said. “They can guide you on correct usage, potential side effects, and interactions with other medications, ensuring both safety and effectiveness,” she explained. The future of birth control pill access The FDA’s approval of Opill as the first over-the-counter birth control pill marked a turning point in contraceptive access in the United States. As new research shows, the impact of OTC birth control availability is reaching those who need it most — uninsured individuals, young people, and those living in rural or underserved areas. For many, OTC birth control provides an opportunity to use reliable contraception or switch from less effective methods. Experts emphasize that access to birth control is not only about preventing pregnancy but also about supporting people’s ability to make decisions about their futures, families, and health on their own terms. As Opill becomes more widely available, it may help close gaps in access and give more people the freedom to choose safe, effective contraception.

Obstructive sleep apnea symptoms may worsen on weekends, a trend researchers are calling “social apnea.” Getty Images A large study found that moderate to severe obstructive sleep apnea symptoms are more likely to occur on weekends, a trend researchers are calling “social apnea.” Late nights, sleeping in, alcohol, and skipping CPAP therapy could be contributing factors. Even without the sleep disorder, irregular weekend routines can cause “social jetlag,” experts say. Keeping a consistent wake-up time, limiting weekend sleep-ins, and alternating alcohol with water can help promote quality sleep.  Late nights and a few drinks might be disrupting your sleep more than you think.  A large international study led by researchers at Flinders University has found that symptoms of obstructive sleep apnea (OSA) — a common sleep disorder that may slow or stop breathing — may tend to worsen on weekends. Researchers coined the term “social apnea” to describe the weekend increase in symptoms, which appear driven by lifestyle habits such as staying up late, sleeping in, and drinking alcohol. Adherence to OSA therapies like CPAP machines may also be less consistent on weekends. The team analyzed data from over 70,000 people worldwide and found participants were 18% more likely to have moderate to severe OSA on weekends (Saturdays) than mid-week (Wednesdays). Sleeping an extra 45 minutes or more on weekends increased the risk of worse sleep apnea by 47%. “Biologically, these habits can relax the muscles in the throat, push sleep into early-morning REM stages (when OSA is often more severe), and throw the body clock out of sync,” Heather Darwall-Smith, a psychotherapist specializing in sleep, who wasn’t involved in the study. told Healthline.  Why ‘social apnea’ may worsen on weekends  Sleep specialist Lindsey Hanna said symptoms of “social apnea” could develop even in those who don’t have obstructive sleep apnea. “We often call it ‘social jetlag,'” she told Healthline. “Your body clock thrives on predictability, and when you shift your schedule by several hours on the weekend, your sleep becomes lighter and more fragmented.” “Even without OSA, people often notice Monday morning grogginess, cravings for sugary foods, and reduced focus. You don’t need a diagnosis of OSA to feel the impact because your circadian system always notices when routines are off,” Hanna continued. Certain individuals may be more susceptible to sleep-related disruptions than others.  “The research found the effect was stronger in men and in adults under 60, but anyone who lives with big swings between weekdays and weekends is likely to notice it,” Hanna said.   “Shift workers, parents of young children, or anyone juggling late nights with early starts are especially vulnerable to weekend-related sleep disruption,” she added.  Long-term effects of poor sleep  Long-term poor sleep — even if it’s only on weekends — can take a toll on physical and mental health. “Even without diagnosed OSA (bear in mind it is massively under-diagnosed), irregular weekend routines can fragment sleep, reduce deep and REM stages, and leave you feeling less rested,” Darwall-Smith said.  “It can also disrupt hormone balance, including leptin and ghrelin. This can lead to increased appetite, food cravings, and gradual weight gain, which in turn can raise OSA risk.”  Late nights and increased alcohol consumption can also impact body weight and appetite hormones.  “Eating large, late meals can disrupt digestion overnight and, over time, contribute to weight gain,” Darwall-Smith explained.  “This is important because extra weight around the neck and upper airway increases OSA risk, while disrupted sleep alters hormones like leptin (which signals fullness) and ghrelin (which triggers hunger), making it harder to maintain a healthy weight.”  Darwall-Smith said these factors can affect mood, focus, and emotional regulation, which may influence a person’s behaviors in relationships, at work, and in daily life. “Beyond the medical side, disrupted sleep also affects patience, communication, and emotional availability,” she explained.  Lifestyle changes to improve sleep quality  If you’re concerned you’re not getting enough quality sleep on the weekends, experts say it’s important to maintain a consistent wake-up time, even on weekends.  “Even if you go to bed later, try not to sleep in too much the next day as that can trigger social jetlag,” Darwall-Smith advised.  For those nights when you don’t get enough quality shut-eye, Hanna recommended short daytime naps, of 30 minutes or less, “rather than prolonged morning sleep to repay sleep debt.” If you’re consuming alcohol, Darwall-Smith noted it’s a good idea to alternate drinks with a nonalcoholic beverage.  “For every alcoholic drink, have a glass of water; this reduces dehydration and may lessen airway relaxation,” she explained.  What and when you eat can impact your sleep quality as well. “Aim to finish large or heavy meals at least two to three hours before bed to aid digestion and reduce night-time reflux, which can worsen breathing disruptions,” Darwall-Smith advised.  You should also carve out time for restful activities on the weekend. For example, Darwall-Smith recommended adding recovery time to your weekend schedule.  “Plan lighter activities the morning after a big night, so you’re not overloading yourself when you’re already short on restorative sleep,” she said.  “What I like about the ‘social apnea’ concept is that it reminds us that sleep health isn’t just a medical issue, it’s relational,” Darwall-Smith said. “It affects how we feel, think, and interact, and, fortunately, small changes in weekend habits can protect not only your health but also the quality of your time with loved ones.”

Heat-induced dehydration can place stress on the heart and raise the risk for serious cardiac events. FG Trade Latin/Getty Images Higher temperatures can raise the risk of heat-related illness, especially for older adults. Extreme heat can place stress on the heart, which could be deadly for those with underlying cardiovascular conditions. A cardiologist shares how extreme heat affects heart function and offers tips for staying heart healthy during hotter weather. As summer draws to a close and extreme temperatures fade into the rearview, heat advisories persist across some parts of the United States. Data from the Centers for Disease Control and Prevention (CDC) show that when the heat index is high, so is the risk of heat-related illness. Cardiovascular risks, especially for older adults living in low socioeconomic status, are of particular concern. A recent study published in Scientific Reports highlights how social determinants of health affect cardiovascular risk. The findings indicate that people living in low-income status with limited healthcare access face higher risks of death from cardiovascular disease. As heat-related health risks are projected to double over the next two decades, the American Heart Association (AHA) warns these risks could be deadly for those with heart disease. Heat-induced dehydration can place stress on the heart and raise the risk for serious cardiac events, such as heart valve failure (HVF).   “Extreme heat exerts significant strain on the cardiovascular system, leading to both immediate and long-term negative effects on heart function,” said Naddi B. Marah, MD, an interventional and structural cardiologist with Memorial Hermann Health System. Healthline recently spoke with Marah to learn more about heat-related cardiovascular risks like HVF and how to protect your heart health during heat waves.   This interview has been lightly edited for clarity. How does extreme heat affect heart function?  Marah: The body’s primary response to high temperatures is peripheral vasodilation, which is the widening of arteries or blood vessels to facilitate heat dissipation. This leads to lower blood pressure and an elevated heart rate.  Additionally, fluid loss, dehydration, and electrolyte imbalances from sweating collectively worsen conditions like heart failure, coronary artery disease, and heart rhythm abnormalities.   In those with heart valve issues or compromised cardiac function, the effects can be far more dangerous.  What’s the difference between heat exhaustion and a serious cardiac event? Marah: This is a very important distinction — and not always a clear-cut one. Heat exhaustion is most likely caused by recent heat exposure and typically includes symptoms like:  heavy sweating fatigue weakness dizziness nausea cool, clammy skin It’s usually related to dehydration from fluid loss and improves with rest, cooling, and rehydration.   However, if someone experiences chest pain, shortness of breath, confusion, palpitations, or low blood pressure, we become more concerned about a cardiac cause, especially if it’s worse with activity, such as feeling short of breath with minimal activities, such as climbing a flight of stairs.  Heart valve failure similarly presents with progressive fatigue, difficulty breathing, rapid weight gain, and an inability to lie flat.  Why are complications of heat-related cardiovascular events? Marah: Heat exposure can act as a cardiovascular stress test. In people with heart valve disease, this additional stress can trigger decompensation, where the heart is unable to pump enough blood to meet the body’s needs.  Older adults, people with longstanding cardiovascular disease, and especially those taking diuretics or other medications affecting fluid balance, are particularly vulnerable during heat waves, as their hearts’ compensatory mechanisms are often impaired.   HVF can worsen with physical activity and often develops swelling in the legs. It is critical to seek medical evaluation if your initial symptoms do not improve rapidly with cooling or hydration. That’s why it’s essential to recognize that heat isn’t just uncomfortable — it’s a legitimate health risk, especially for those with known or suspected cardiovascular issues.  Who is most at risk for HFV and other underlying heart conditions?  Marah: Individuals most at risk for HFV and other underlying heart conditions are adults over 65, and those with other medical conditions, such as:  high blood pressure diabetes high cholesterol obesity kidney disease A family history of cardiovascular disease also raises your risk, especially if close relatives had heart valve problems or cardiac events at a young age.  If you’re experiencing symptoms such as shortness of breath, fatigue, swelling in the legs, palpitations, or fainting spells, those can be signs that your heart valves aren’t functioning properly.   How can you protect your heart health during extreme heat?  Marah: Protecting your heart during heatwaves involves both lifestyle adjustments and, in some cases, medication management.  Some key strategies include:  staying well-hydrated avoiding outdoor strenuous activity during peak heat using air conditioning or seeking cool environments dressing in light, breathable fabrics  Most importantly, monitor for early symptoms of decompensation, including shortness of breath, chest pain, and palpitation.  Don’t hesitate to review your medications with your doctors, and ask if dose adjustments may be necessary during heatwave alerts.   I always tell people, “Don’t wait for symptoms to take the lead.” See your cardiologist for a simple screening, which can catch heart valve issues early and keep your heart beating strong for years to come.

Research on GLP-1 drugs and eye health has been inconsistent, but experts say the risk of serious eye disease is generally low. Getty Images/Hiraman Studies have linked GLP-1 medications to various eye conditions, some of which may lead to vision loss. Despite these findings, a clear link has yet to be established, and much of the evidence remains inconsistent. People should be aware of potential eye disease and blindness risks when discussing a GLP-1 with their doctor. The debate over whether GLP-1 medications raise the risk of eye conditions that could lead to vision loss continues. Scientists have been closely studying this association as more people turn to these widely prescribed drugs for weight management. Some studies have suggested a link, but the overall evidence has been inconsistent. However, when a potential side effect becomes as serious as vision loss or blindness, even a remote possibility is worth investigating. GLP-1 drugs are a class of medications used to treat obesity and type 2 diabetes that include semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound). They work by mimicking naturally occurring hormones that help regulate blood sugar, promote satiety, and reduce appetite. While GLP-1s are generally well tolerated and offer numerous health benefits — from weight loss and better glucose control to a lower risk of cardiovascular disease — research suggests they could increase the risk of certain serious eye conditions. Previous research has linked GLP-1 drugs to a sudden, vision-threatening condition called nonarteritic anterior ischemic optic neuropathy (NAION) and to “wet” age-related macular degeneration. The risk of developing these conditions is relatively low. However, they are serious and should be factored into the risk–benefit discussion when considering GLP-1 therapy with a doctor. As a flurry of new research offers a clearer picture of how GLP-1 drugs may affect eye health, Healthline spoke with experts to help break down the findings. GLP-1 drugs and eye disease Three new studies investigated the link between GLP-1s and eye disease, but each employed distinct methods and arrived at different conclusions. A new study compared the effects of semaglutide or tirzepatide with other antidiabetic medications — such as insulin and metformin — on optic nerve conditions, including NAION, in patients with type 2 diabetes. The retrospective cohort study, published on August 11 in JAMA Network Open, included nearly 160,000 patients, evenly split into two groups: one taking GLP-1s and one taking other antidiabetic medications. Over two years of follow-up, those taking a GLP-1 had higher rates of NAION and other optic nerve conditions than those in the comparison group. There were 93 patients with other optic nerve disorders in the semaglutide or tirzepatide group, and 54 patients with these disorders in the comparison group. The study did not specify the types of other optic nerve disorders. “Newer GLP-1RAs have lots of benefits. This study provides evidence of their potential risks. For each patient, the risk-benefit tradeoff critically depends on a patient’s clinical characteristics and their preferences and clinicians’ recommendations,” senior study author Rong Xu, PhD, professor and director of the Center for AI in Drug Discovery at Case Western Reserve University, told Healthline. A separate retrospective study, also published in August in the same journal, reached a different conclusion. In a large cohort of patients with type 2 diabetes, researchers found that GLP-1 use was not associated with a higher incidence of NAION but was linked to another eye condition: diabetic retinopathy. During a two-year follow-up, 5,037 patients taking a GLP-1 developed diabetic retinopathy, compared with 4,938 who were not — a 7% increased risk. In a twist, the study found that although there was a small increase in diabetic retinopathy, GLP-1 use appeared to protect against the condition’s progression and sight-threatening complications. A subgroup of patients in the study had pre-existing diabetic retinopathy. Those who took a GLP-1 had a lower risk of complications, including progression to proliferative diabetic retinopathy, diabetic macular edema, vitreous hemorrhage, and neovascular glaucoma. They were also less likely to require medical, surgical, or laser treatments for their eyes. Most notably, GLP-1 use was associated with a significantly lower incidence of blindness from any cause. Another study — a meta-analysis and review of 78 trials involving more than 73,000 participants — concluded that semaglutide was associated with an increased incidence of NAION but emphasized that evidence for a causal link remains inconclusive. The review, published on August 14 in JAMA Ophthalmology, found that semaglutide neither increased nor reduced the risk of eye disorders, including diabetic retinopathy. It’s important to note that all three studies can only identify correlations and cannot establish that taking a GLP-1 causes these eye disorders. Studies so far have also focused almost exclusively on patients with type 2 diabetes, so it’s unclear what effect GLP-1s have on eye conditions in individuals taking them for weight loss. Making sense of GLP-1s and eye health If you’re having trouble making sense of what these conflicting findings mean — especially if you already take a GLP-1 or are considering one — you’re not alone. Here’s a quick summary on GLP-1s and various eye conditions, and what experts have to say about them: NAION NAION causes sudden blindness in one eye, usually after waking, that is caused by a lack of blood flow to the optic nerve. The condition is elusive, and not well understood. The condition is serious, but despite an apparent increased incidence among patients taking GLP-1s, the condition is still uncommon. “NAION is rare in general,” said Xu.  “For patients with high risk of developing NAION (e.g., those with diabetes, hypertension) who are taking GLP-1RAs, ophthalmologists may increase vigilance,” she said. Linda Lam, MD, MBA, an ophthalmologist with Keck Medicine of USC, who wasn’t involved in the research, tells Healthline that it’s too early to make a “definitive connection” between NAION and GLP-1s.  “To make a correlation that GLP-1s cause NAION would be a big leap,” she said.  Diabetic retinopathy Diabetic retinopathy is a complication of type 1 and type 2 diabetes that may lead to vision loss. It is the most common cause of preventable blindness in the United States. Though it may seem counterintuitive, antidiabetic medications that improve blood glucose may worsen this condition. “It’s better to be cautious and protective with vision. So, if a patient has started on a GLP-1 and they already have some diabetic retinopathy, I would just have them come in sooner to see their eye care provider,” said Lam. “Wet” age-related macular degeneration A recent study published in June found that patients with type 2 diabetes who took GLP-1s were more than twice as likely to develop wet AMD as those who did not. Researchers also identified a dose response, meaning that the longer the patients took a GLP-1, the more likely they were to develop the condition. However, there still needs to be more research to substantiate this link. “We need to have a lot more studies before we can make these cause and effect determinations. But, anyone who has neovascular AMD and is on a GLP-1 needs to be monitored more closely,” said Lam. The bottom line: GLP-1s have many health benefits, and while there is some evidence to support an association between them and serious eye conditions, that link should not be overstated, and must be considered within the greater context of your individual health. Patients with diabetes should get regular eye exams, regardless of whether they are taking a GLP-1, but taking the medication may be one more reason to schedule an exam. “GLP-1s have potentially good long-term effects for long-term health in patients with diabetes or obesity. But doctors should be much more cautious and aware of visual complications while they’re on these medications, especially when their glycemic numbers go down rapidly. The threshold for when to see your eye care provider or retina specialist should be lower,” Lam said.

GLP-1 drugmaker Eli Lilly’s new weight loss pill orforglipron showed meaningful weight loss results in a recent clinical trial. Scott Olson/Getty Images Eli Lilly’s new oral GLP-1 medication orforglipron produced an average weight loss of 12.4% (27.3 pounds) in clinical trials. The weight loss pill also significantly improved heart health markers like cholesterol and blood pressure. Experts note that some may prefer the flexibility of a weight loss pill compared to the injectable version. Eli Lilly is on track to apply for FDA approval by late 2025, the drugmaker announced. A groundbreaking new oral medication for weight management has shown promising results in a recent large-scale clinical trial, offering hope to millions with obesity and related health issues.  Orforglipron, developed by Eli Lilly, is an investigational daily pill that mimics the effects of injectable GLP-1 receptor agonists, a class of drugs known to help with weight loss and blood sugar control.  In its pivotal Phase 3 ATTAIN-1 trial, which involved over 3,000 adults with obesity or overweight, orforglipron demonstrated significantly higher weight loss compared to a placebo.  Participants titrating up to the highest dose of 36 milligrams lost an average of 12.4% of their initial body weight (27.3 pounds) over the course of the 72-week study. Lower doses (6 milligrams and 12 milligrams) also showed clinically significant weight reductions of 7.8% and 9.3%, respectively.  Beyond weight loss, orforglipron improved heart health markers while maintaining a safety profile similar to existing treatments. These improvements included lower levels of non-HDL cholesterol, triglycerides, and systolic blood pressure. At the highest dose, it also reduced high-sensitivity C-reactive protein (hsCRP) by 47.7% With regulatory submissions planned by the end of 2025 and a global launch on the horizon, here is everything you need to know about the new weight loss pill from Eli Lilly. What is orforglipron? Injectable glucon-like peptide-1 (GLP-1) medications have skyrocketed in popularity due to their clinically significant effects on weight loss and the management of certain health conditions. This class of drugs, sometimes referred to as GLP-1 receptor agonists, includes Wegovy (semaglutide) and Zepbound (tirzepatide). Diabetes medications Ozempic and Mounjaro are often prescribed off-label for weight management. Unlike injectable GLP-1 drugs, orforglipron is not a peptide. Peptides are naturally occurring short chains of amino acids whose synthetic versions have found applications in many areas, such as skin care, bodybuilding, and weight loss, due to their ability to trigger desirable effects in the human body. While orforglipron is not a peptide, it can activate the glucagon-like peptide-1 receptor in the same way as GLP-1 medications. “Orforglipron is a new kind of GLP-1 medication known as a small-molecule oral GLP-1 receptor agonist,” explained Rekha Kumar, MD, an obesity medicine specialist and head of medical affairs at Found. This means orforglipron can be taken in pill form to achieve similar effects, including weight loss and other improvements in metabolic health, like better blood sugar control, lower blood pressure, and reduced cholesterol. Are weight loss pills as effective as injectable GLP-1s? Once-daily oral versions of GLP-1 drugs could replace the need for once-weekly injections, but Eli Lilly isn’t the only drug manufacturer with a weight loss pill in the works. Competitor Novo Nordisk’s weight loss pill has also produced meaningful weight loss results in clinical trials. The Food and Drug Administration (FDA) recently accepted Novo Nordisk’s application to produce its oral version of Wegovy. While clinical trials for both drugmakers’ weight loss pills have yielded positive results for weight loss, experts say they may not always be as effective as injectable counterparts. “That’s because orforglipron is a non-peptide, small-molecule pill, so it doesn’t bind to the GLP-1 receptor quite as strongly as injectable peptide medications, which mimic our body’s natural GLP-1 hormone,” Kumar explained. “Even so, the results are still very good by any health standard, and for people who prefer a pill over an injection, it’s an effective alternative to help reach weight-care goals,” Kumar told Healthline. Some people might prefer weight loss pills over injectables Some people may prefer current injectable GLP-1 medications due to their potential for greater weight loss or the simplicity of weekly injections. For others, the convenience of a once-daily pill like orforglipron might seem more appealing. Kumar noted that many people might prefer a pill over needles, or not having to worry about refrigeration or structured rules about when to inject the medication. According to Eli Lilly’s press release, orforglipron can be taken at any time of the day without restrictions on food and water intake. “It’s a great option for people who want a simpler, needle-free treatment that fits easily into busy or unpredictable schedules — like parents, frequent travelers, or anyone who dislikes injections,” Kumar said. There are also the dual factors of cost and availability. Kumar said you can “expect manufacturing and storage to be easier and cheaper for a pill like this, so once someone starts, they’re less likely to face the shortages we saw after Wegovy and Zepbound launched.” This could make orforglipron more accessible to many people, Kumar noted. Side effects of weight loss pill similar to other GLP-1s Meghan Garcia-Webb, MD, triple board certified in internal medicine, lifestyle medicine, and obesity medicine, and an internist at an academic medical center in Boston, noted that orforglipron has shown potentially mild to moderate gastrointestinal side effects. These include nausea, vomiting, constipation, and diarrhea. As Eli Lilly stated in a press release, this is consistent with the overall safety profile of other drugs in this class. About 1 in 10 individuals at the highest tested dose dropped out of the study due to these adverse effects. Importantly, Eli Lilly also stated that there were no observed signs of liver-related side effects. “Overall it seems like a very promising alternative offering similar results to Wegovy with a similar side effect profile to current GLP-1 RA weight medications,” said Garcia-Webb. When will Lilly’s weight loss pill be available? Eli Lilly announced they’re planning to submit orforglipron to the FDA for weight loss this year. Garcia-Webb said this means the pill could be approved as early as 2026. The drugmaker stated that Orforglipron’s positive Phase 3 ATTAIN-1 trial results have put it on track to submit to global regulatory agencies by the end of 2025. They are also making substantial investments to meet anticipated demand at launch. This indicates that orforglipron could become available to consumers following regulatory approval. However, Eli Lilly cautions about the risks and uncertainties in drug development. There are no guarantees that orforglipron will be approved or make it to market on the anticipated timeline. In the meantime, Novo Nordisk’s weight loss pill could come to market sooner, but an exact timeline remains unclear. Learn more about how to get GLP-1 medications from vetted and trusted online sources here: Where to Buy Ozempic Online Where to Buy Ozempic Online How to Get Mounjaro (Tirzepatide) Where to Buy Mounjaro (Tirzepatide) Online How to Get Wegovy for Weight Loss In Person and Online How to Get a Wegovy Prescription Online How to Get Zepbound: What We Know So Far Where to Buy Zepbound Online

The “One Big Beautiful Bill” will cut $1 trillion from health-related programs like Medicaid, Medicare, and the ACA over the next decade. MoMo Productions/Getty Images The tax and spending bill approved by Congress last month will cut $1 trillion from health-related programs over the next decade. The “One Big Beautiful Bill” will hit Medicaid hardest with $790 million chopped from its budget. Experts say these reductions will greatly impact health programs across the country, particularly those serving rural communities, children, and lower-income households. The so-called One Big Beautiful Bill Act (OBBBA), signed by President Donald Trump in early July, will impact virtually every health-related program in the United States. The bill, officially known as House Resolution 1, is expected to reduce federal spending on health-related programs by $1 trillion between now and 2034. It’s estimated that those cuts will cause at least 10 million people to lose health insurance coverage during the next nine years. It calls for a reduction in funding for food assistance programs and rural hospitals, as well as reduced funding for Planned Parenthood services, which have been temporarily blocked by a federal judge. Some of these impacts will take years to be felt. Other provisions, however, could directly affect people’s lives in the next year or two. ”It is the biggest cut to our social safety net in history,” Liz Fowler, PhD, a distinguished scholar in Health Policy and Management at the Bloomberg School of Public Health at Johns Hopkins University in Maryland, said in a news release from the college. Here’s a look at six key areas affected by spending reductions outlined in President Trump’s “Big Beautiful Bill.” Medicaid bears the brunt of the cuts Federal funding for Medicaid is expected to be reduced by more than $790 billion over the next decade. More than 70 million people currently receive Medicaid benefits, but various factors could significantly reduce this estimate. Work requirements will mandate that most “able-bodied” recipients between the ages of 19 and 64 will be required to work, receive work training, volunteer, or be in school for at least 80 hours per month while receiving benefits. The new work requirements take effect on January 1, 2027. As many as 5 million people could lose health insurance due to this requirement, according to the Kaiser Family Foundation (KFF). More frequent eligibility checks will require states to verify beneficiaries’ eligibility for Medicaid more often, causing some recipients to be removed from the program. Immigration restrictions will reduce the number of foreign-born residents receiving benefits. The cuts may also affect hospitals, as Medicaid is responsible for 20% of revenue at these medical facilities nationwide. Experts also point out that people who are no longer on Medicaid will not seek preventive care and end up in hospital emergency rooms due to more serious medical issues. “Cutting Medicaid means millions lose access to basic care, leading to sicker patients, overwhelmed ERs, and rising costs for everyone,” said Kanwar Kelley, MD, a specialist in otolaryngology, head and neck surgery, obesity medicine, and lifestyle medicine as well as the co-founder and chief executive officer of Side Health. “Lack of access to preventive care leads to a sicker population, which leads to more medical expenses,” Kelley told Healthline. Impacts to Medicare Medicare is a federal program founded in 1965 that provides health insurance coverage to people 65 years and older. About 66 million Americans are enrolled. Trump’s bill does not directly mention Medicare cuts, but there are measures that could impact recipients. Under a 2010 budget mechanism law known as PAYGO, the Congressional Budget Office estimates the Trump bill could trigger more than $500 billion in Medicare cuts between 2026 and 2034, KFF reports. The Center for Medicare Advocacy notes the bill will also reduce the number of people eligible for Medicare. They say some non-citizens who meet Medicare eligibility requirements through work history or residency length will no longer be covered. In addition, the bill imposes a nine-year ban on implementing improvements to Medicare Savings Programs that help lower-income Medicare beneficiaries pay for premiums and out-of-pocket costs. Older adults who are enrolled in both Medicaid and Medicare could hit with a double impact. “The [bill] will affect this [older] age range by reducing access to care,” Kelley said. “Creating restrictions based on work requirements and new regulations for exemptions will exclude many in this age group from qualifying. Those in this age range will have a harder time re-entering the workforce to continue their coverage.” Fewer people enrolled in Obamacare The bill will make it more difficult for people to join or remain in programs offered by the Affordable Care Act (ACA), also known as Obamacare. This difficulty will be due to several changes. They include: Requiring enrollees to update their information regularly. This may include updating income, immigration status, and other details each year. Requiring individuals to manually reenroll every year during open enrollment. Last year, 10 million people were automatically reenrolled. Shortening the open enrollment period by a month. That period will now end on December 15 rather than January 15. For the current plan year, 40% of people signed up after December 15. Some immigrants will also no longer be eligible for ACA coverage. In addition, financial assistance that helps people afford insurance in ACA marketplaces will be allowed to expire at the end of this year. The Bloomberg School of Public Health at Johns Hopkins University predicts these changes will cause ACA premiums to rise by 75% next year. Kelley agrees that premiums will likely go up, causing a cascade of events. “Removing or cutting these subsidies will lead to more expensive plans offered on the marketplace. By raising these prices, many will choose to live without health insurance and risk catastrophic medical debt,” he said. “Making access to healthcare harder for individuals creates gaps in care for patients, which is crucial in screening for life-altering illnesses.” Strains on rural hospitals The bill does provide rural hospitals with $50 billion over the next five years to help reduce the effects from the cuts in Medicaid spending. However, the Center for American Progress reports that funding will not be nearly enough to make up the difference. The organization states that slightly more than 2,000 rural hospitals receive $12 billion per year in net revenue from Medicaid. At some rural hospitals, Medicaid represents 40–50% of their revenue. The organization added that children, non-elderly adults, and people with disabilities would be the people in rural areas most affected. Kelley agreed that the effects could be far-reaching. “This loss of funding will hit rural hospitals hard, leading to closures and increasing healthcare disparities in marginalized neighborhoods,” he said. The Center for American Progress also notes that rural hospitals have low operating margins. They project that more than 300 rural hospitals could be at risk of closure. “Rural communities already face challenges with adequate staffing and medically necessary equipment as they usually operate on tight margins with the subsidies,” Kelley said. “Reducing the number of providers will lead to closures, which forces those in the community to travel farther for their regular and emergency care.” Fewer families will receive food assistance The bill would cut $120 billion from the Supplemental Nutrition Assistance Program (Supplemental Nutrition Assistance Program (SNAP) over the next decade, according to estimates. About 40 million people currently receive assistance from the SNAP program. The League of Women Voters projects the cuts could impact 22 million families. Kelley said the impact is beyond just food. “Food insecurity leads to bad health outcomes,” he said. “Cutting programs directed at addressing hunger will lead to increased rates of obesity, diabetes, and poor nutrition in kids.” “Hunger in children leads to poor educational outcomes. Cutting SNAP and other food programs will lead to children going to school hungry, seniors skipping meals, and families making decisions between food and other necessities, including health,” Kelley added. Cuts to Planned Parenthood The bill impacts Planned Parenthood operations by banning people from using Medicaid at healthcare non-profit facilities that provide abortion services outside of cases of rape, incest, or when the pregnant person’s life is in danger. Planned Parenthood estimates that the new law could close nearly 200 of its facilities. About 60% of those centers are in medically underserved communities. In addition, the organization states that more than 1 million people could lose access to afford healthcare services such as STI testing and birth control. Miller Morris, MA, MPH, is a women’s health researcher and founder of Comma, a service focusing on menstrual health. She notes that a court injunction has temporarily blocked the bill’s ban on Medicaid use at reproductive health clinics like Planned Parenthood. However, she said if the provisions are eventually upheld, they could have far-ranging effects. “If the court’s injunction were to be lifted, the defunding of Planned Parenthood would mean fewer resources for all the preventative and primary care services they offer, leading to reduced access for millions of women, especially those in low-income and rural communities,” Morris told Healthline. “This reduction in Medicaid funding will see catastrophic consequences for the millions of women who rely on Planned Parenthood and similar low-cost organizations for vital, life saving care,” she added. “As Planned Parenthood is also a crucial provider of prenatal and pregnancy care, it’s clear that this isn’t about saving babies. It’s about exerting control over women,” Miller said.

Healthier ultra-processed foods tend to have more nutrients, while less healthy options are loaded with sugar, unhealthy fats, and salt. Catherine Falls Commercial/Getty Images The American Heart Association (AHA) suggests that not all ultra-processed foods (UPFs) are bad for you.  Certain processing methods help keep foods safe, nutritious, and affordable without sacrificing quality.  Healthier UPFs tend to have more nutrients, while less healthy options are loaded with sugar, unhealthy fats, and salt.  Choosing UPFs with better ingredients and nutrient profiles can support convenience without harming long-term health. Ultra-processed foods (UPFs) have developed an unhealthy reputation, but not all UPFs are created equally.   A new scientific advisory from the American Heart Association (AHA) has challenged the idea that all ultra-processed foods are unhealthy.  While many ultra-processed foods have been linked to adverse health outcomes, the advisory, published on August 8 in Circulation, offered a more nuanced perspective. For instance, AHA scientists argue that some UPFs appear to have better nutritional profiles and can fit into an overall healthy diet. UPFs are typically high in saturated fats, added sugars, and sodium, and can contribute to adverse cardiometabolic health outcomes, including heart attack, stroke, obesity, inflammation, type 2 diabetes, and vascular complications. Yet as a press release about the advisory notes, “certain types of industrial food processing are beneficial for preservation and safety, and/or lowering cost, such as techniques that extend shelf life, control microbial growth, mitigate chemical toxicants, preserve functional, nutritional and sensory (taste) qualities, and reduce food loss and waste.” While there’s plenty of evidence indicating that junk foods are harmful to health, the new AHA report suggests there may be a few processed foods you can include in your diet in moderation. Some ultra-processed foods healthier than others “Healthier UPFs are those that, despite undergoing industrial processing, still offer nutritional benefits, such as fiber, protein, vitamins, and minerals, and have limited amounts of added sugars, unhealthy fats, and sodium,” said Nichola Ludlam-Raine, a registered dietitian and author of “How Not To Eat Ultra-Processed.”  Some examples of healthier ultra-processed foods include: whole grain breads high-fiber breakfast cereals certain dairy products fortified plant-based milks “In contrast, ‘less healthy’ UPFs are typically low in nutritional value and high in added saturated fat, sugars, and salt, or multiple additives (which can encourage the passive overconsumption of calories),” Ludlam-Raine said. “The key difference often lies in the ingredients and nutrient profile, not just the processing,” she added.  Samantha Peterson, MS, RDN, functional medicine dietitian and founder of Simply Wellness, agreed. She said some of the worst UPFs include: sugar-sweetened beverages refined snack foods instant noodles processed meats “These are often high in rapidly absorbed sugars or refined starches, inflammatory fats, sodium, and other additives; a combination that can drive blood sugar spikes, gut imbalance, chronic inflammation, and increased risk for heart disease, diabetes, and certain cancers,” she explained.  “Over time, high intakes of low-nutrient UPFs can contribute to obesity, insulin resistance, high blood pressure, elevated cholesterol, gut microbiome disruption, and higher risks for cardiovascular disease and certain cancers,” she continued.  What to look for on nutrition labels While some ultra-processed foods have little to no redeeming qualities, others can provide essential nutrients and offer convenience for busy lifestyles. Experts recommend paying attention to nutrition content on food labels and reading the list of ingredients carefully. “When choosing UPFs, I recommend looking for items such as bread or cereals with 3 grams or more fiber per serving,” Ludlam-Raine advised.  She added that people should opt for products such as yogurt with 5–10 g of protein and reduced or no added sugar options.  Fortified products are another item to look out for. Ludlam-Raine said that foods fortified with added calcium, vitamin D, B12, iron, and iodine can help boost your intake of key nutrients.  If in doubt, “a shorter, more recognisable ingredient list is often (though not always) a good sign,” she said.  Similarly, Peterson said it’s a “good sign” if the first few ingredients listed on a label include whole foods (i.e., oats, beans, milk, salmon, etc.). Healthier ultra-processed foods It can be helpful to have a specific list of examples. Ludlam-Raine said some healthier processed foods include: Fortified whole grain breakfast cereals. These can be a good source of fiber, iron, and B vitamins, but it’s a good idea to avoid those containing added sugar. Plant-based milks (i.e., fortified soy or almond milk without added carrageenan). “These are often enriched with calcium and iodine, which are important nutrients especially for those avoiding dairy,” Ludlam-Raine said.  Canned beans (including baked beans) and pulses in water. “These are technically UPFs due to industrial tinning and the addition of firming agents, but they are a natural and great source of plant protein and fiber,” she said. Rinsing beans thoroughly can help reduce sodium content. Whole grain sliced bread. “So long as it’s low in salt and sugar, it provides fiber and complex carbohydrates for sustained energy,” she explained.  Greek-style or plain yogurts with live cultures. “These can support gut and bone health,” she noted. Ludlam-Raine added that these foods contribute positively to nutrient intake and offer convenience, which is an important factor for overall health. Ultra-processed foods in moderation  Many processed foods offer convenience, affordability, and important nutrients, especially for those with limited time or budget.  For example, canned beans, whole grain breads, and fortified plant milks provide fiber, protein, and vitamins while needing minimal prep. Peterson said that “processing isn’t inherently bad.” She noted that freezing, fortifying, or canning can preserve nutrients and support public health.  Both experts agreed that balance is key. Swapping sugary drinks for sparkling water or white bread for whole grain, while planning simple meals that mix fresh, frozen, and healthier UPFs, can make a real difference. Ludlam-Raine recommended adopting an 80:20 rule: 80% whole foods with 20% offering leeway for healthier processed foods. She advised keeping less healthy UPFs as occasional rather than daily choices and encourages using a food diary to identify small but impactful changes. Choosing healthier ultra-processed foods in moderation can allow you to take advantage of convenience without sacrificing long-term health.

GLP-1-related hair loss is usually a temporary side effect, and there are treatments available to help facilitate hair regrowth. Bondarillia/Getty Images Some individuals taking GLP-1 drugs have reported hair loss as a possible side effect. The exact cause of GLP-1-related hair loss is unclear, but experts say it could be attributed to weight loss from the medication. This form of hair loss is considered temporary, and treatments are available to help facilitate hair regrowth. Significant weight loss is one of the hallmarks of GLP-1 drugs, but some people have claimed that their hair is vanishing along with the excess pounds. Although hair loss isn’t an officially listed side effect of GLP-1 drugs — a class of medications used to treat obesity and type 2 diabetes, including Wegovy, Ozempic, and Zepbound — anecdotal reports and emerging research suggest that it’s a real phenomenon. “It’s definitely a common thing that we’re seeing in the office,” said Marisa Garshick, MD, a board certified dermatologist and clinical assistant professor of dermatology at Weill Cornell Medicine. However, just because a side effect is common doesn’t mean it’s well understood. There is little published literature on GLP-1-related hair loss, and it remains unclear how prevalent the condition is or what’s causing it. Most experts believe any resulting hair loss isn’t caused by the drugs themselves, but rather by the weight loss they induce. “We don’t think of it as something specifically unique to the GLP-1s, insofar as any kind of stress placed on the body — be it physical, like surgery, or emotional, psychological, or a lifestyle change — can sometimes contribute to a type of hair shedding called telogen effluvium,” said Garshick. GLP-1-related hair loss is generally temporary, though it may take time for hair to grow back. Several treatment options are available — from diet and lifestyle changes to supplements, prescription medications, and more. What causes sudden hair loss? Telogen effluvium is a common type of sudden hair loss that typically results from stress or shock. Common triggers may include: childbirth menopause polycystic ovary syndrome (PCOS) Other causes include nutrition deficiencies, endocrine disorders, and, yes, dramatic weight loss. “GLP-1 associated hair loss is unique in that the continued weight loss is a continued ‘stressor,'” said Jenni Holman, MD, FAAD, a diplomate of the American Academy of Dermatology. “Unlike a singular exposure or event, the ongoing weight loss often slows the body’s ability to reset the hair shedding cycle. As opposed to shedding hair over a few weeks, the hair shedding may continue throughout the weight loss process,” Homan explained. Since this type of hair loss is likely linked to weight loss and not the GLP-1 drug itself, shedding may not start for months after beginning treatment.  Telogen effluvium tends to resolve once the underlying stressor has been addressed. However, it may take several months before hair volume is restored. “Generally, we can reassure patients that it’s a temporary process that does tend to get better with time,” Garshick said. GLP-1 hair loss vs. other forms of hair loss Telogen effluvium or sudden hair loss differs from other forms of hair loss in significant ways. Here’s a closer look. androgenic alopecia — The most common cause of hair loss that affects up to 50% of males. The condition also affects females, with a higher prevalence after menopause. It’s caused by a combination of age, genetics, and hormones. Male pattern baldness and female pattern baldness are both forms of androgenic alopecia. alopecia areata — An autoimmune condition that causes the immune system to attack hair follicles. tinea capitis — Also known as ringworm of the scalp, it is a fungal infection that causes small bald patches that may be scaly or itchy. “The way we distinguish it typically is by the sudden onset of hair shedding that typically occurs with telogen effluvium,” Garshick said. “It’s usually more diffuse, so you’ll notice hair loss from everywhere, as opposed to androgenetic alopecia, which may be more of a localized area.” What to do when shedding starts If you notice increased hair shedding, Holman suggests taking a quick inventory of your personal history: “Are there any new medications, stresses, illnesses, or major body [or] life changes in the last three months?”  Diet and other lifestyle factors can have serious effects on hair health, so paying attention to what you’re eating and general stress level are good places to start. Since most people who take GLP-1s eat less, this may affect diet quality and potentially lead to nutritional deficiencies. “When hair loss occurs, I check for possible vitamin and iron deficiencies, which can be associated with hair loss. Vitamin D deficiency is common. I also check zinc levels,” said Sun Kim, MD, an associate professor of Endocrinology at Stanford Medicine. Protein deficiency during weight loss can also exacerbate hair loss, so Kim advises all patients to consume adequate protein while taking a GLP-1 drug. In some cases, slowing the rate of weight loss may be an effective strategy to mitigate hair loss while also maintaining the benefits of the GLP-1 medication. Do supplements work for GLP-1-related hair loss? Garshick noted that robust scientific evidence to support the effectiveness of certain supplements for hair loss is still lacking. “There are certain [supplements] where, anecdotally, we’ve had success and certainly I’ve had patients who have done very well,” Garshick said. Nutrafol, a clinically studied hair loss supplement, has been shown to improve hair regrowth. Other popular supplements include Viviscal and Wellbel. Remember that nutritional supplements are not approved by the Food and Drug Administration (FDA), so do your due diligence before purchasing such products. “I recommend nutraceuticals [for hair loss] with some dose of skepticism because they are expensive,” said Kim. Holman cited some common over-the-counter supplements that may aid hair regrowth by directly addressing dietary deficiencies, such as iron or vitamin C. Such supplements may also be comparatively inexpensive. “Supplements are most helpful if the hair loss is related to a true deficiency of a nutrient,” she said. Serums and shampoos for hair loss There are some topical serums with substantial evidence to support their effectiveness. Holman recommended platelet-derived exosome serums. However, like supplements, the evidence for serums, where it exists at all, will vary, as will results. Even if serums and other leave-in products don’t directly impact hair loss, they may still support scalp and hair health, which can support hair regrowth. Some types of shampoos may also be helpful. “There’s a shampoo ingredient called ketoconazole that may be something to consider, especially if you have some underlying predisposition to androgenetic alopecia, in the context of the telogen effluvium,” Garshick said. “Ketoconazole shampoo or other medicated shampoos that have key ingredients like peptides or biotin can help to strengthen, volumize, and support the hair while we’re waiting for it to grow back,” she added. Can minoxidil help GLP-1-related hair loss? Minoxidil has been approved for use by the FDA since the mid-1980s to help facilitate hair regrowth. The medication promotes hair growth through anti-inflammatory, vasodilating, and anti-androgenic effects. It’s available as both an oral pill and a topical liquid or foam. “Low-dose oral minoxidil is a mainstay of treatment for most types of hair loss,” Holman said.  “While it doesn’t specifically reset the shedding of telogen effluvium that correlates with new medications and weight loss, it does help overall hair growth.” PRP, red-light therapy may promote hair regrowth Platelet-rich plasma (PRP) uses a person’s own blood to isolate plasma, concentrate it, and then inject it into the body. It’s believed to promote healing and hair regrowth. “When we do that, it helps to stimulate the hair follicles to speed up that regrowth process,” Garshick explained. “So for some patients who they feel like the process is dragging on and they’re not noticing hair regrowth, sometimes this can speed it up.” The benefits of PRP treatment for hair loss haven’t definitively been proven, though a 2014 study found that it was effective in treating androgenic alopecia. Red light therapy may also benefit hair regrowth and can be performed at home using a specialized hat or helmet.  Holman noted that PRP injections and red and orange laser light caps can “achieve a synergistic effect with oral anti-androgens and supplements.” How long does it take for hair to grow back? Regrowing hair takes time, especially if you are continuing to lose weight with GLP-1 medication. “Typically, if the weight stabilizes, the hair should too,” Garshick said. “But, because hair takes a long time to grow, sometimes you might not see those changes for six to twelve months.” Holman provided a slightly longer estimate: “If the GLP-1 hair loss is solely the telogen effluvium type hair loss, yes, the body can reset itself.  Typically, once weight remains stable, the body will begin to reset the shedding cycle. However, this can take 12-18 months once weight is stable.” If you’re concerned about GLP-1-related hair loss, consulting a board-certified dermatologist may be a good first step. “A very real option is also not doing anything. In some cases, it’s better for patients to be heard, evaluated, and just be reassured that things will get better with time,” Garshick said. Although sudden hair loss can be concerning, remember that it’s likely a temporary side effect. Ask your prescribing physician about hair loss and what you can do about it before making any changes to your medication. Learn more about how to get GLP-1 medications from vetted and trusted online sources here: Where to Buy Ozempic Online Where to Buy Ozempic Online How to Get Mounjaro (Tirzepatide) Where to Buy Mounjaro (Tirzepatide) Online How to Get Wegovy for Weight Loss In Person and Online How to Get a Wegovy Prescription Online How to Get Zepbound: What We Know So Far Where to Buy Zepbound Online

New research has found that consuming three or more servings of French fries per week is associated with a 20% increased risk. Kobus Louw/Getty Images Eating French fries three or more times a week is linked to a 20% higher risk of developing type 2 diabetes. Experts say the way fries are processed and cooked, including added sugars, refined oils, and high heat, plays a major role in raising the risk. Fries are considered an ultra-processed food that may impact blood sugar, gut health, and inflammation when eaten regularly. An occasional serving of fries is unlikely to cause harm, but it’s recommended to limit intake and focus on balanced, whole-food meals to support metabolic health. Love a side of fries? New research cautions that moderation is key.  Eating fried potato products like French fries three times weekly is linked to a higher risk of developing type 2 diabetes (T2D). Researchers followed over 150,000 participants over several decades and found that those who ate fried potatoes frequently were more likely to develop T2D compared to those who ate them less often.  The study, published on August 6 in The BMJ, showed that consuming three or more servings of French fries per week is associated with a 20% increased risk. Experts say the findings highlight well-established concerns over ultra-processed food consumption and the role these foods play in blood sugar regulation and long-term health. Fries, other ultra-processed foods negatively impact health Nichola Ludlam-Raine, a registered dietitian and author of “How Not to Eat Ultra-Processed,” wasn’t involved in the new study but said she isn’t surprised by the findings. “French fries are a form of ultra-processed food high in refined carbohydrates, fat (often from unhealthy oils due to the re-heating and reuse of them), and calories,” she told Healthline. A 2022 meta‑analysis of 1.1 million people found that moderate intake of ultra‑processed foods (UPFs) is linked with a 12 % higher risk of developing type 2 diabetes (and up to 31 % higher risk with high consumption). While potatoes are naturally rich in fiber, potassium, and vitamins C and B6, it’s how they are prepared that matters.  “Frying potatoes increases their energy density (calories per gram) and often introduces harmful compounds like trans fats or advanced glycation end products, especially when oils are reused,” said Ludlam-Raine. “Frying also breaks down some of the natural fiber and increases the glycemic response.” Caroline Roberts, a nutritional therapist at Integral Wellness, explained that industrially prepared fries go through multiple steps that can raise their glycemic index. Roberts wasn’t involved in the new study. “For the big chain fast food restaurants and any frozen French fries you buy in the supermarket, the skin of the potato is removed, removing most of the fiber content and immediately raising the glycemic index,” she told Healthline. “Once cut and washed, sugar is added as part of the preparation process before they are cooked, which ensures they have the golden brown colour we all know, but raises the glycemic index of the fries further.” Roberts added that the part-boiling and part-frying process increases fat content and gelatinizes starch, which may cause a rapid rise in blood glucose levels. Then there are the extra ingredients to consider.  “Ultra-processed foods like French fries often contain additives, preservatives, emulsifiers, and refined oils that aren’t typically used in home cooking,” Ludlam-Raine noted. “These can negatively impact the gut microbiome, promote inflammation, and contribute to insulin resistance over time.” A comprehensive review involving nearly 10 million participants linked UPF consumption to at least 32 adverse health outcomes, including type 2 diabetes, among others such as: cardiovascular disease obesity mental health conditions premature death Fries in moderation unlikely to cause harm Some good news? If you enjoy French fries, you don’t have to swear off them forever.  “Overall dietary pattern is crucial when assessing diabetes risk,” Roberts said. A healthy diet that emphasizes whole foods with adequate protein, fiber, and healthy fats can help minimize the risk of type 2 diabetes. Therefore, Roberts noted, the occasional serving of fries can be enjoyed as part of a balanced diet. Ludlam-Raine agreed that French fries should be consumed in moderation rather than regularly. “While an occasional portion isn’t likely to cause harm, habitual intake matters,” she said. “I’d recommend limiting fries and similar foods to no more than once every couple of weeks and ensuring meals are balanced to help stabilize blood sugar.” Like other ultra-processed foods, however, French fries are designed to be highly palatable, which may trigger cravings and lead to overconsumption and raise blood sugar levels, Roberts noted. Refined carbs may spike blood sugar The new research also flagged white rice as a potential contributor to type 2 diabetes. Like French fries, white rice can be digested quickly and cause blood sugar spikes.  “White rice has been stripped of its fibrous outer layer,” said Roberts. “Without fiber, white rice is rapidly digested and can raise blood sugars significantly in some people.” Ludlam-Raine explained that “refined carbohydrates are quickly broken down into glucose, causing rapid rises in blood sugar and insulin levels. These foods lack the fiber, vitamins, and minerals found in whole grains, which help slow digestion and support metabolic health.” This doesn’t mean white rice is off the menu entirely. Pairing it with protein and healthy fats can prevent rapid blood sugar spikes.  If you’re looking for an alternative, experts recommend simple swaps, like brown rice, bulgur, or quinoa.  A balanced diet helps lower diabetes risk If you’re worried about your type 2 diabetes risk or you’re looking to reduce your intake of French fries, there are lots of ways you can make healthier choices.  If you want to make something similar to French fries at home, Roberts advised cutting white potatoes into wedges, keeping the skin on to retain the fiber content, and using an air fryer to cook them so that no oil is needed.  “Cooked and reheated white potatoes have a much lower glycemic index because the process of cooling and reheating them activates their resistant starch content,” she explained.  Ludlam-Raine recommended “homemade oven-baked potato or sweet potato wedges using olive oil and herbs” as an easy alternative. It’s what you eat day to day that truly matters most.  Both experts stressed the importance of building meals with blood sugar balance in mind: focus on whole food protein sources, fiber-rich vegetables, and healthy fats. To help lower your risk of type 2 diabetes, Ludlam-Raine offered a few nutrition tips: Include fiber at every meal from vegetables, whole grains, pulses, nuts, and seeds. Prioritize protein, like eggs, fish, tofu, or beans. Choose healthy fats, such as olive oil, avocado, and oily fish. Limit less nutritious ultra-processed foods and sugary drinks. Roberts added that hydration and balanced snacking also play a role in supporting blood sugar regulation. Ultimately, most experts agree it’s the overall pattern of what you eat that matters most.  “Making small, sustainable swaps, like choosing whole grains over refined carbs and preparing meals at home more often, can significantly reduce long-term risk,” said Ludlam-Raine.

RFK Jr.’s decision to pull funding for mRNA vaccines could thwart public health responses to future pandemics. Anna Moneymaker/Getty Images HHS Secretary Robert F. Kennedy Jr. announced the agency will pull $500 million in funding for 22 mRNA vaccine development programs. Kennedy criticized mRNA vaccines, claiming the evidence-based technology “failed to protect” against respiratory diseases like COVID-19 and influenza. Experts say terminating funding for mRNA vaccine programs could impact public health responses to future pandemics and the fight against cancer and other diseases. The U.S. Department of Health and Human Services (HHS) announced on August 5 that it will withdraw $500 million in funding from vaccine development projects. The decision follows what the agency described as a comprehensive review of mRNA-related investments that began during the COVID-19 public health emergency. “We reviewed the science, listened to the experts, and acted,” HHS Secretary Robert F. Kennedy Jr. said in a statement shared with Healthline. “We’re shifting that funding toward safer, broader vaccine platforms that remain effective even as viruses mutate.” Kennedy said the decision to terminate 22 mRNA vaccine development projects is based on data showing that the vaccines “fail to protect effectively against upper respiratory infections like COVID and flu.”  Some final-stage contracts with vaccine makers (i.e., Arcturus and Amplitude) have been granted permission to conclude their projects, but no new mRNA-based projects will be allowed.   “Let me be absolutely clear: HHS supports safe, effective vaccines for every American who wants them. That’s why we’re moving beyond the limitations of mRNA and investing in better solutions,” Kennedy said. The shift in health policy aligns with Kennedy’s ongoing skepticism over vaccine safety and effectiveness. The Health Secretary has criticized mRNA technology on his social media platforms, scaled back recommendations for COVID-19 shots, dismissed the CDC panel that recommends vaccines, and has been generally skeptical of vaccination against measles amidst a growing outbreak. The HHS attests that vaccines developed against COVID-19 that were funded for emergency use “failed to meet scientific standards” and will be replaced with “evidence-based solutions,” such as whole-virus and novel platforms. In a news conference following the HHS announcement, Kennedy said the administration’s next focus is a “universal vaccine” that mimics “natural immunity,” the Associated Press reported. mRNA vaccines considered safe, effective Public health experts have expressed concern over the agency’s move. Most experts support the large body of evidence showing that mRNA is a safe and effective, evidence-based technology for fighting respiratory diseases like COVID-19, influenza, and respiratory syncytial virus (RSV).  mRNA vaccines have also shown promise as treatments for certain forms of cancer and other chronic diseases. “These vaccines have been used in millions of doses around the world and have been subject to very careful scrutiny as to their effectiveness and safety by the Ministries of Health of many countries around the world, not just our own,” said William Schaffner, MD, an infectious disease specialist and a professor of medicine at Vanderbilt University in Nashville. “The latest technology, which has been [around] for over 20 years, burst upon the scene when scientists were able to very quickly create the extraordinarily effective and safe mRNA COVID-19 vaccines,” he told Healthline. “Having federal seed money that spurs further research withdrawn is very, very disappointing, and certainly will slow further development.” Universal vaccines vs. mRNA vaccines Kennedy said that health officials and scientists will shift their focus to developing universal vaccines against respiratory illnesses that mimic natural immunity. Universal flu vaccines are still in development, but some studies have shown promising results. Schaffner explained that a universal influenza or COVID-19 vaccine would protect against a variety of constantly mutating flu or SARS-CoV-2 strains. Current vaccines against respiratory illnesses like the coronavirus, which were until recently, being constantly updated, are indeed strain-specific in that they’re designed to target a particular dominant strain to fight against severe illness.  A universal vaccine would protect us against strains that have yet to emerge and potentially offer longer-term protection compared to current mRNA vaccines. “That’s a wonderful goal, but we shouldn’t stop investigating any technology,” Schaffner said. “Withdrawing funding from further development of mRNA vaccines is contrary to a better public health in the future. With vaccines, newer technology allows us to prevent more diseases. And of course, the prevention of disease is medicine’s most noble and highest goal.” Schaffner noted that pulling funds from mRNA research could also thwart preparedness against the next respiratory disease pandemic, be it bird flu, another coronavirus, or some not-yet-discovered pathogen. “I’m optimistic — but optimism doesn’t drive science,” Schaffner said.

Deion ‘Coach Prime’ Sanders is raising awareness about getting screened for bladder cancer. Ed Zurga/Getty Images University of Colorado football coach Deion Sanders shared he was successfully treated for bladder cancer after having his bladder removed. ‘Coach Prime’ said the cancer was detected early after he underwent a routine CT scan to monitor his other health conditions. Experts say it’s particularly important for men over 50 to get screened for bladder cancer since the disease can be treated if caught in its early stages. University of Colorado football coach Deion Sanders is getting the word out about bladder cancer screenings after his close call with the disease. ‘Coach Prime,’ 57, said that medical professionals detected bladder cancer after he underwent a routine CT scan earlier this year. In a recent press conference, the former two-sport star said the early diagnosis led to successful bladder surgery, and he is now “cured” of his cancer. “Men — everybody — get checked out because if it wasn’t for me getting tested for something else, they wouldn’t have stumbled upon this,” said Sanders, who played professional football and baseball. “And make sure you go to get the right care because without wonderful people like this, I probably wouldn’t be sitting here today.” Sanders went in for his CT scan this spring because of previous issues he had with blood clots and chronic vascular disease that led to the amputation of two of his toes last year. The scan revealed there was a tumor in Sanders’ bladder. Surgeons removed the tumor and learned the cancer had invaded the bladder wall but had not yet reached the muscular layer beyond the wall. Janet Kukreja, MD, a robotic surgery expert at the University of Colorado School of Medicine, said at the press conference that she recommended bladder removal because, without that surgery, there was a 50% chance the cancer would return. “I am pleased to report that the results from the surgery are that he is cured from the cancer,” Kukreja said. Sanders said he went public with his diagnosis and treatment to help save lives. “We are helping some folks today. There’s some folks right now calling their doctors, scheduling checkups,” he said. Experts say Sanders is offering good advice. “It is important to understand that the earlier bladder cancer is diagnosed, the less involved the treatment and increase in the rate of cure,” said Ramkishen Narayanan, MD, an urologist and urologic oncologist and the director of the Center for Urologic Health at The Roy and Patricia Disney Family Cancer Center at Providence Saint Joseph Medical Center Occupational in California. Stages and risks of bladder cancer The American Cancer Society (ACS) estimates there will be about 85,000 new cases of bladder cancer in the United States in 2025. About 65,000 of those cases will be males. More than 90% of people diagnosed with bladder cancer are over the age of 55, with the average age of diagnosis being 73. The ACS projects that about 17,000 people in the U.S. will die from bladder cancer this year. About 12,000 will be males. Bladder cancer is the 10th leading cause of cancer death in the U.S. Bladder cancer death rates have decreased by about 1% per year since 2013. The stages of bladder can vary. The five stages are: Stage 0: Cancer hasn’t spread beyond the bladder lining Stage 1: Cancer has spread past the lining of the bladder Stage 2: Cancer has spread to the layer of the muscle in the bladder Stage 3: Cancer has spread to tissues surrounding the bladder Stage 4: Cancer has spread to neighboring areas of the bladder The 5-year survival rates for bladder cancer are vastly different, depending on the stage. According to the National Cancer Institute, there is a 97% survival rate for cancer that hasn’t spread past the lining of the bladder but only an 8% survival rate for cancer that has spread to other parts of the body. Jack Jacoub, MD, a medical oncologist and the medical director of MemorialCare Cancer Institute at Orange Coast and Saddleback Medical Centers in California, told Healthline there is a big difference between low risk bladder cancer in its early stages and the high risk version in the latter stages. He said cancer spreading to the muscle layer and surrounding tissues is “the critical point in the development of bladder cancer.” Jacoub said it’s not entirely clear how bladder cancer develops. He noted that, like the colon, the bladder stores waste products, and the chemicals from those products can leak into surrounding layers and tissues. “The bladder at the end of the day is a reservoir,” he explained. Symptoms and treatment for bladder cancer Bladder cancer occurs when abnormal bladder cells divide and grow out of control. These cells can form a tumor and eventually spread to surrounding muscles and organs. The number one risk factor is smoking. About 50% of bladder cancer cases are linked to smoking. The ACS reports that people who smoke may be three times more likely to develop bladder cancer than people who don’t smoke. “Smoking hands down is the biggest risk factor,” Jacoub said. Sanders has never smoked, so it’s clear there are still other risk factors. They include exposure to certain chemicals, a family history of the disease, and chronic bladder infections. “Cigarette smoking is the dominant risk factor — carcinogens are inhaled, filtered by [the] kidneys into urine, and exposed to the bladder,” noted Narayanan. “Exposures — aromatic amines and dyes found in industries such as metal, leather, painting and hair-coloring, plastics manufacturing, and firefighting — significantly elevate risk,” he told Healthline. The most common symptoms of bladder cancer are: blood in the urine painful urination frequent urination urgent urination urinary incontinence Bladder cancer can also cause pain in the abdomen and lower back, as well as fatigue, loss of appetite, and swollen feet. The disease is usually initially detected from lab tests, such as a urinalysis. Doctors may then order tests such as a cystoscopy, a biopsy, or a CT scan for further diagnosis. The treatment for bladder cancer depends on the stage at which it is discovered. In the early stages, doctors may elect to simply remove the tumor and/or order chemotherapy or immunotherapy for the patient. In later stages, doctors may decide to remove part or all of the bladder as well as order chemotherapy, radiation, and immunotherapy. “Bladder cancer is often treatable, especially when found early,” Eugene Shkolyar, MD, a clinical associate professor of urology at Stanford University in California, told Healthline. “The most important determinant in treatment is what type of bladder cancer is found.” Deion Sanders’ bladder removed during cancer treatment In Sanders’ case, doctors elected to take out his entire bladder. In that type of surgery, doctors first remove the bladder. Next, they cut out about a foot and a half of the end section of the small intestine known as the ileum. Surgeons then slice that section of the ileum so it lies flat. Then they fold the section in half and attach the back end to the front end. The surgeon then secures this neobladder to the kidneys and urethra. The neobladder doesn’t function like the original bladder because it doesn’t send signals to the brain to let a person know when to urinate. People like Sanders who have neobladders undergo training to learn to control their urination functions during the day. However, there is usually leakage when the person is asleep. Shkolyar said the recovery after bladder removal can be a long road. “After bladder removal (cystectomy) recovery can take several months,” he said. “This is a major operation that involved not only removing the bladder but also re-routing the urinary tract using the intestines. Patients first focus on regaining bowel function and learning how to manage their urinary system. Afterward, the focus is on return to good nutrition, physical strength, and function. This can take up to three months for some.” At a recent press conference, Sanders acknowledged he now “depends on Depends.” He noted there will probably be a portable toilet on the field when he coaches University of Colorado football games. Sanders said it’s important that people talk about these issues. “I know there’s a lot of people out there going through what I’m going through. And dealing with what I’m dealing with,” he said. “And let’s stop being ashamed of it.” Shkolyar said follow-up appointments are crucial for anyone who has been treated for bladder cancer. “No matter the treatment, ongoing follow-up is important to watch for recurrence and manage any side effects,” he said. “Support from multidisciplinary healthcare teams with expertise in bladder cancer is critical.” Sandip Prasad, MD, the surgical director of genitourinary oncology and vice chair of urology at Morristown Medical Center in New Jersey, a part of the Atlantic Health System, agrees that consistent check-ins with medical professionals is crucial for people who have had bladder cancer. “For all bladder cancer patients, there will be a lifetime of follow-up to ensure the disease does not recur,” Prasad told Healthline. “For this reason, your relationship with your urologist is critically important to maintain good communication, preserve quality of life, and achieve a long and healthy life as a bladder cancer survivor.”

James Van Der Beek is raising awareness about rising colorectal cancer rates in young people. Photography courtesy of Guardant Health James Van Der Beek shares his journey with early onset colorectal cancer after being diagnosed at 46. The former “Dawson’s Creek” star is spreading awareness about the rising cases of colorectal cancer in young people. Van Der Beek teamed up with Guardant Health to inform others about the importance of colon cancer screening and early detection. At 46 years old, actor James Van Der Beek noticed minor changes in his bowel movements. “There wasn’t any red flag or something glaring,” he told Healthline. However, out of caution, the “Dawson’s Creek” star felt the need to see his doctor. After undergoing a colonoscopy in August 2023, Van Der Beek learned he had colorectal cancer. “I was healthy. I was doing the cold plunge. I was in amazing cardiovascular shape, and I had stage 3 cancer, and I had no idea,” he said. Because his cancer occurred before age 50, it is considered early onset colorectal cancer. Rates of early onset colorectal cancer in the United States have nearly doubled since the early 1990s. In 1994, the incidence rate was 4.8 cases per 100,000 people, and in 2021, it rose to 10.1 per 100,000 people. “With this upward trend of 2–4% annually, gastroenterologists and colorectal surgeons are very concerned that we may not be capturing the full scope of the disease early enough, particularly in asymptomatic younger individuals who do not meet traditional risk-based criteria,” Paul Johnson, MD, surgical oncologist with Methodist Le Bonheur Healthcare, told Healthline. In 2018, due to the alarming rise in the incidence of young-onset colorectal cancer, the American Cancer Society lowered the screening age for average-risk patients from 50 to 45. In 2021, the U.S. Preventive Services Task Force (USPSTF) echoed this recommendation, stating that colon cancer screening should begin for all adults ages 45–49. A research letter published on August 4 in JAMA Network notes that the 50% increase in colorectal cancer incidence from 2021 to 2022 is likely a reflection of the recent changes to colon cancer screening guidelines for adults under 50. Getting screened for colon cancer can lead to early detection, which improves survival and decreases the likelihood of needing chemotherapy, immunotherapy, or radiation, Johnson noted. When colorectal cancer is caught in early stages, survival is over 90%. A doctor can help determine if a stool-based test that looks for cancer is the best option or if a colonoscopy, which examines the colon and rectum, is best. “The proverb ‘an ounce of prevention is worth a pound of cure’ is very apropos because we know that if we remove polyps, an abnormal growth in the lining of the colon or rectum, we can interrupt the pathway of that polyp becoming cancer,” Johnson said. While colonoscopy remains the gold standard of screening and can detect polyps with remarkable accuracy, he said, the procedure also allows doctors to remove the polyps on the spot, thereby preventing development into cancer. However, he noted that newer options, such as stool DNA-based colorectal cancer screening tests and the FDA-approved blood-based test Shield, have introduced additional options. To encourage people to get screened, Van Der Beek partnered with Guardant Health to raise awareness about the Shield blood test. “I really want to impress upon people that you don’t need symptoms to get screened. If you are 45 or older or have a family history, talk to your doctor about your screening options,” he said. Healthline talked with Van Der Beek to hear more about his cancer journey and why he is speaking out. This interview has been lightly edited and condensed for clarity and length. What should people to know about colon cancer? Van Der Beek: I want to unpack the numbers. It is the second leading cause of cancer death, but if you look closer, it’s also the most curable. I really want people to understand that [when found] in the early stages, the survival rates skyrocket. Before my diagnosis, I didn’t know much about colorectal cancer. I didn’t even realize the screening age dropped to 45; I thought it was still 50. Just put [screening] on your radar, even if you’re young, even if you’re healthy because unfortunately cases are rising, especially in younger, healthier people. Did your diagnosis give you a new perspective on life? Van Der Beek: Oh, for sure. I think I take things a little bit more slowly. I think I’ve learned to really appreciate the small moments and to let go of the things that would’ve upset me prior. It’s really taught me a lot about myself, how important self-love is, and how important positive self-talk is. It’s really made me take a good, hard look at who I am. How did your cancer diagnosis affect your mental health? Van Der Beek: It is challenging. In the beginning, one thing I used to say a lot was, “This is harder than I thought it would be.” I would say find out who you can lean on and ask for help. Really find who your people are and reach out. You can’t do this alone. That was the biggest [challenge] for me because I never asked for help. And what I realized was just how many people were there to show up for me, how I’d been wronging them of the opportunity to show up because I try to do everything all the time. How important is preventive healthcare? Van Der Beek: Colorectal cancer just wasn’t on my radar before, so yeah, I’ve got a much greater awareness and I’m the one telling all my friends to talk to their doctor, find out about screening options. What I love about the Shield test is it’s convenient, simple, FDA approved — it’s a simple blood draw and it could be done at your next doctor’s appointment. Obviously, colonoscopy is still the gold standard for screening, but for anybody who has barriers around that, what they found is that adherence to a colonoscopy recommendation is not that great. But people are three times more likely to adhere to [screening] advice when it’s just a blood test. It’s convenient for people who either can’t take off work to do a colonoscopy or who [face] other barriers to some of the other testing methods. How does it feel to share your cancer journey? Van Der Beek: It is really life affirming. I feel like it’s a big part of my healing process to spread the word and to help anybody I can from having to go through what I have been through. Using a platform for a purpose is definitely a lot more fun than trying to push my next project, which I’m not above doing. [I] get to spread the word and feel like everything I’ve been going through has purpose.